{"text": "However , it is an excellent model for assessing PTH - lowering activity in the background of severe kidney dysfunction .In this study , plasma PTH levels were significantly reduced by a single dose of either AMG 416 or cinacalcet .", "label": "", "metadata": {}, "score": "33.311943"}
{"text": "We can not support the direct effect of combined therapy on bone turnover , which is an important component of mineral and bone metabolism .Therefore , further prospective long - term studies are necessary to confirm the beneficial effects of a combined therapy of low - dose cinacalcet and calcitriol on renal bone pathology .", "label": "", "metadata": {}, "score": "34.248238"}
{"text": "To the best of our knowledge , the second study was the only one that prospectively examined bone histomorphometric parameters in 10 transplant recipients before and after 18 - 24-month treatment with cinacalcet [ 68 ] .", "label": "", "metadata": {}, "score": "37.71544"}
{"text": "In addition , Block et al . reported its benefit of cardiovascular protection in a large observational study for hemodialysis subjects [ 16 ] .More recently , considerable evidences also exhibited that combination administration of a low dose of vitamin D and stepped - up cinacalcet provide apparent efficacy in treating UHPT [ 17 , 18 , 19 ] .", "label": "", "metadata": {}, "score": "37.98934"}
{"text": "At the start of the study , the six patients treated with cinacalcet showed a more severe picture of biochemical abnormalities when compared with the control patients .", "label": "", "metadata": {}, "score": "38.542946"}
{"text": "In this paper , we sought to directly compare the efficacy of these two compounds in two different uremic rodent models .In addition , we examined the activity of AMG 416 in a model of chronic uremia , in rats under 5/6 nephrectomy in order to compare the efficacy of AMG 416 and cinacalcet over repeated dosing during a 28-day administration period .", "label": "", "metadata": {}, "score": "39.19139"}
{"text": "Change in rates may be due to other factors occurring simultaneously with the introduction of cinacalcet .For example , following the publication of the KDOQI Guidelines use of more aggressive treatments such as higher doses of phosphate binders and vitamin D may explain lower PTX rates with time [ 1 , 19 ] .", "label": "", "metadata": {}, "score": "39.519962"}
{"text": "Whether the new less calcemic vitamin D analogues would represent a clinical advantage also in this field deserves specific prospective studies .Although the potential effects of cinacalcet treatment on bone metabolism in KTx patients is an important issue , only two papers have dealt with this problem .", "label": "", "metadata": {}, "score": "39.79676"}
{"text": "Unfortunately , only intravenous vitamin D analogues were available in Li et al .[5 ] study , therefore use of phosphate binders , cinacalcet and oral vitamin D was not reported .", "label": "", "metadata": {}, "score": "40.189564"}
{"text": "Our study also showed similar benefits of combined therapy .Meanwhile , a lower dose of cinacalcet , which is sufficiently effective to suppress iPTH levels , has been observed in Japanese patients [ 27 ] .", "label": "", "metadata": {}, "score": "40.634346"}
{"text": "On the other hand , the behavior of PTH levels was less homogeneous .It is also worth - underlining that only a part of these studies reported on the effect of cinacalcet on urinary calcium excretion .", "label": "", "metadata": {}, "score": "41.275772"}
{"text": "Discussion .The 1K1C model is a severe , acute model of renal dysfunction which enables the activity of AMG 416 and cinacalcet to be investigated in the presence of the highly elevated levels of PTH and lack of kidney function typically seen in CKD - MBD patients receiving hemodialysis [ 1 ] .", "label": "", "metadata": {}, "score": "41.482643"}
{"text": "Repeat administration of AMG 416 results in extended reduction of PTH in renally compromised rats .Rats subjected to 5/6 nephrectomy were treated daily for 28 days with either : AMG 416 ( 1 mg / kg administered by IV bolus ) , saline ( IV bolus ) or cinacalcet ( 10 mg / kg administered po ) .", "label": "", "metadata": {}, "score": "41.690487"}
{"text": "The data were expressed as mean?SD and as percentage .NS , not significant .Page 4 .Two other patients treated with cinacalcet ( one affected by carcinoma of the parathyroid glands and the other by nodular hyperplasia ) maintained serum levels of iPTH of 600pg / ml .", "label": "", "metadata": {}, "score": "41.77968"}
{"text": "Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant .Drug : Cinacalcet . cinacalcet , 30 mg daily , titrated to achieve serum phosphorus of 2.5 mg / dl , versus placebo , similarly titrated .", "label": "", "metadata": {}, "score": "41.940372"}
{"text": "Prevention and treatment of secondary hyperparathyroidism remain a continuous challenge for the nephrologist , despite availability of phosphate binders , active vitamin D analogues and more recently , cinacalcet .", "label": "", "metadata": {}, "score": "42.164177"}
{"text": "Our study provides supportive evidence that combination therapy of low - dose cinacalcet and calcitriol was effective to treat moderate and severe UHPT .Furthermore , our results demonstrated that low - dose cinacalcet as an add - on therapy to standard treatment including calcitriol and phosphate binders improved goal attainment of CKD - mineral bone disease over low - dose calcitriol alone .", "label": "", "metadata": {}, "score": "42.607925"}
{"text": "Several studies showed that the cinacalcet group received lower dose of vitamin D and exhibited lower level of PTH , compared with those receiving conventional vitamin D based therapy [ 14 , 18 ] .", "label": "", "metadata": {}, "score": "42.833244"}
{"text": "In the same model , oral treatment with cinacalcet ( 30 mg / kg ) resulted in an acute drop in PTH which almost returned to the starting level by 24 hours after dosing .", "label": "", "metadata": {}, "score": "43.193542"}
{"text": "Moreover , efficacy of cinacalcet may be limited in some patients by its gastrointestinal adverse effects , which may be more frequent in real - world patients compared to selected patients enrolled in a randomized - controlled trial .", "label": "", "metadata": {}, "score": "43.262615"}
{"text": "Abstract .BACKGROUND :In kidney transplant recipients , persistent hyperparathyroidism leads to hypercalcemia and increased urinary phosphorus excretion .The calcimimetic drug cinacalcet effectively decreases parathyroid hormone ( PTH ) levels and corrects hypercalcemia in these patients .", "label": "", "metadata": {}, "score": "43.308975"}
{"text": "205 , pp .67 - 78 , 1983 .View at Google Scholar .N. Leca , M. Laftavi , A. Gundroo et al . , \" Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "43.352127"}
{"text": "Table 3 ) , thus , well before the introduction of calcitriol in the treatment .Thus , we can conclude that our single - centre prospective study , even though small and of short duration , shows that cinacalcet represents a solid , and sometimes unique , therapeutic opportunity for patients affected by relapses of SHPTH after PTx .", "label": "", "metadata": {}, "score": "43.44104"}
{"text": "However , no data about the treatment with cinacalcet of relapses of SHPTH after PTx are available in literature .The aim of this single - centre prospective study was to evaluate the therapeutic efficacy of cinacalcet in this high - risk category of patients .", "label": "", "metadata": {}, "score": "43.595863"}
{"text": "Our single - centre prospective study , even though small and of short duration , shows that cinacalcet is effective also in controlling relapses of SHPTH after PTx , thus representing a solid , and sometimes unique , therapeutic opportunity for this high - risk category of patients .", "label": "", "metadata": {}, "score": "43.696327"}
{"text": "Our single - centre prospective study , even though small and of short duration , shows that cinacalcet is effective also in controlling relapses of SHPTH after PTx , thus representing a solid , and sometimes unique , therapeutic opportunity for this high - risk category of patients .", "label": "", "metadata": {}, "score": "43.696327"}
{"text": "In addition , phospho - soda has been associated with phosphate nephropathy and renal failure .Cinacalcet HCl is a calcimimetic agent that has recently become a standard therapy in the treatment of SHPT in ESRD .", "label": "", "metadata": {}, "score": "44.156822"}
{"text": "Cinacalcet has also been used to control hypercalcemia in renal transplant patients with persistent hyperparathyroidism .Short - term cinacalcet given for 2 to 4 weeks has normalized serum phosphorus and decreased urinary phosphate wasting in renal transplant recipients with stable graft function .", "label": "", "metadata": {}, "score": "44.207836"}
{"text": "The aim of this single - centre prospective study was to evaluate the therapeutic efficacy of cinacalcet in the metabolic control of relapses of SHPTH after PTx .", "label": "", "metadata": {}, "score": "44.63939"}
{"text": "So , any metabolic change which might potentially increase this risk should be considered with great caution .To reinforce this concern , a case of nephrocalcinosis which occurred in a KTx patient treated with cinacalcet has been recently reported [ 62 ] .", "label": "", "metadata": {}, "score": "44.654396"}
{"text": "In conclusion , our single - centre prospective study , even though small and of short duration , shows that cinacalcet is effective also in controlling relapses of SHPTH after PTx , thus representing a solid , and sometimes unique , therapeutic opportunity for this high - risk category of patients .", "label": "", "metadata": {}, "score": "44.970932"}
{"text": "After 6 months of treatment , a statistically significant reduction in the serum levels of iPTH , Ca , P and CaxP product was obtained only in the patients treated with cinacalcet .", "label": "", "metadata": {}, "score": "45.341072"}
{"text": "All these studies homogeneously demonstrated that cinacalcet is effective in reducing serum calcium concentration .Another constant finding of these studies was a consistent increase in serum phosphorus levels .", "label": "", "metadata": {}, "score": "45.420906"}
{"text": "Cinacalcet was maintained at 25 mg until iPTH was less than 150 pg / mL. The dosage of the phosphate binder and vitamin D sterols , either oral or intravenous calcitriol , was elastically titrated or discontinued temporarily according to iPTH and calcium phosphate product ( Ca \u00d7 P ) levels as per K / DOQI and KDIGO guidelines recommendation .", "label": "", "metadata": {}, "score": "45.71768"}
{"text": "Discussion The efficacy of cinacalcet compared with placebo in decreasing PTH concentrations in haemodialysis patients with SHPTH was shown in several published studies [ 10 - 13 ] , thus increasing the percentage of subjects who are able to achieve the NKF / K - DOQI targets [ 7,9].", "label": "", "metadata": {}, "score": "45.830147"}
{"text": "Test compounds .AMG 416 was prepared as described previously [ 5 ] .Cinacalcet was prepared from commercial tablets as a suspension in normal saline .", "label": "", "metadata": {}, "score": "46.0933"}
{"text": "Among the 52 patients under- going PTx , five died owing to clinical causes not related to PTx , seven underwent renal transplantation .Among the remaining 40 patients , four underwent a second PTx because of either the persistence or the precocious relapse ( in the first six months after the operation ) of SHPTH .", "label": "", "metadata": {}, "score": "46.227364"}
{"text": "These side effects advised us to be more prudent in increasing the doses of cinacalcet .These episodes indicate a greater difficulty in metabolic compensation in patients after PTx , whose causes remain to be elucidated .", "label": "", "metadata": {}, "score": "46.297943"}
{"text": "Serra , A L ; Wuhrmann , C ; W\u00fcthrich , R P ( 2008 ) .Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism .", "label": "", "metadata": {}, "score": "46.31572"}
{"text": "Administration of AMG 416 by IV bolus injection into rats with acute renal dysfunction ( 1K1C model ) resulted in a sustained reduction in plasma PTH from the initial elevated values .", "label": "", "metadata": {}, "score": "46.35354"}
{"text": "Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca , P , PTH and dose of active vitamin D in peritoneal dialysis patients : a randomized controlled study .", "label": "", "metadata": {}, "score": "46.838844"}
{"text": "In contrast , the half - life of cinacalcet is independent of kidney function [ 11 ] , as the main route of clearance is through hepatic mechanisms [ 12 ] .", "label": "", "metadata": {}, "score": "46.844925"}
{"text": "Kidney Int .2009 , 76 , S1-S130 .Clin .Nephrol .[ Google Scholar ] .Martin , K.J. ; Gonz\u00e1lez , E.A. ; Gellens , M. ; Hamm , L.L. ; Abboud , H. ; Lindberg , J. 19-Nor-1-alpha-25-dihydroxyvitamin D2 ( paricalcitol ) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis .", "label": "", "metadata": {}, "score": "47.11482"}
{"text": "No data about the treatment with cinacalcet of relapses of SHPTH after PTx are available in literature .Thus , the successful response of our patients to cinacalcet is the in vivo mirror of the in vitro evidence of the suppressive effect of cinacalcet on parathyroid cells with patholo- gically reduced CaSR levels [ 23].", "label": "", "metadata": {}, "score": "47.158497"}
{"text": "Since cinacalcet is not the only factor that changed over the study period , phosphate binders ( sevelamer , lanthanum , calcium - containing , and magnesium and/or aluminium - containing ) and vitamin D use was also measured .", "label": "", "metadata": {}, "score": "47.206852"}
{"text": "It is a very effective agent , producing significant reduction of PTH as well as improvement in calcium and phosphate metabolism in the dialysis patient .", "label": "", "metadata": {}, "score": "47.255665"}
{"text": "However , following studies , though performed in small groups of patients , provided results which suggest that cinacalcet might reduce Tacrolimus . by approximately 14 % and might also promote the accumulation of a nephrotoxic metabolite of cyclosporine ( AM19 ) [ 75 , 76 ] .", "label": "", "metadata": {}, "score": "47.418633"}
{"text": "The aim of this single - centre prospective study was to evaluate the therapeutic efficacy of cinacalcet in this high - risk category of patients .", "label": "", "metadata": {}, "score": "47.53546"}
{"text": "Besides , the prescribed dose of cinacalcet was 30.2 \u00b1 18.0 mg / day during assessment phase , which means our subjects received lower dose of cinacalcet than that reported in other studies [ 14 , 18 ] .", "label": "", "metadata": {}, "score": "47.568962"}
{"text": "Combination Therapy of Low - Dose Cinacalcet and Calcitriol to Reduce Hypocalcemia Episodes and Use of Aluminum Hydroxide .The most reported side effect of cinacalcet treatment is gastrointestinal disorders , including nausea , vomiting , and diarrhea [ 29 ] .", "label": "", "metadata": {}, "score": "47.759216"}
{"text": "RESULTS : Cinacalcet decreased renal phosphorus excretion in the first 8 hours by 30 % to 40 % , but not from 8 to 24 hours after drug administration .", "label": "", "metadata": {}, "score": "47.932056"}
{"text": "The resulting pharmacodynamic behavior for cinacalcet in this study is also consistent with previously published results [ 9 ] .Although treatment with both agents reduced PTH shortly after dosing ( 6 hr post treatment ) , only AMG 416 was associated with sustained PTH reductions throughout and beyond the dosing interval .", "label": "", "metadata": {}, "score": "48.152824"}
{"text": "Kidney Int .[ Google Scholar ] .Goodman , W.G. ; Hladik , G.A. ; Turner , S.A. ; Blaisdell , P.W. ; Goodkin , D.A. ; Liu , W. ; Barri , Y.M. ; Cohen , R.M. ; Coburn , J.W. The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism .", "label": "", "metadata": {}, "score": "48.34571"}
{"text": "No subjects in the control group took cinacalcet throughout the study period .PTH and biochemical parameters .Mineral metabolic parameters at each scheduled visit for both groups .", "label": "", "metadata": {}, "score": "48.52234"}
{"text": "This fact enhances the complexity of the indication for PTX for the patients on a transplant waiting - list who suffer from a severe form of SHP which is well controlled by cinacalcet .", "label": "", "metadata": {}, "score": "48.56455"}
{"text": "This might have introduced a selection bias , where only patients with previously recognized severe hyperparathyroidism were included .Third , the time elapsed from the time of transplantation to the time when serum calcium levels were evaluated was consistently variable in the different studies .", "label": "", "metadata": {}, "score": "48.62298"}
{"text": "Additionally , cinalcalcet reimbursement was conditional on specific criteria as detailed previously , and physicians were encouraged to use vitamin D and phosphate binders to gain access to cinacalcet for their patients .", "label": "", "metadata": {}, "score": "48.800064"}
{"text": "Because of diverse mechanisms in the pathogenesis of UHPT , the concept of combination therapy of cinacalcet and low - dose vitamin D emerged , and clinicians can now use vitamin D more actively due to lower calcium and phosphorus levels during cinacalcet treatment .", "label": "", "metadata": {}, "score": "48.80872"}
{"text": "The subjects were not allowed to change dialysate calcium concentration during the entire study period and could not change cinacalcet and vitamin D dosage during the efficacy - assessment phase .", "label": "", "metadata": {}, "score": "49.015686"}
{"text": "Acknowledgment .This study was supported by the grant \" Project Glomerulonephritis \" in memory of Pippo Neglia .References . H. Y. Yakupoglu , A. Corsenca , P. Wahl , R. P. W\u00fcthrich , and P. M. Amb\u00fchl , \" Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "49.116493"}
{"text": "More than two - thirds of the patients in each group had received phosphate binders : 28 ( 84.8 % ) for the cinacalcet group and 25 ( 75.6 % ) for the control group .", "label": "", "metadata": {}, "score": "49.201416"}
{"text": "577 - 583 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. Szwarc , A. Argil\u00e9s , V. Garrigue et al . , \" Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "49.21228"}
{"text": "919 - 924 , 2008 .View at Google Scholar .P. Falck , N. T. Vethe , A. \u00c5sberg et al . , \" Cinacalcet 's effect on the pharmacokinetics of tacrolimus , cyclosporine and mycophenolate in renal transplant recipients , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "49.23893"}
{"text": "At the start of the study , the six patients treated with cinacalcet showed a more severe picture of biochemicalabnormalities the control patients ( Table 2 ) : in fact , they had higher mean serum levels of iPTH ( 1388.3 ?", "label": "", "metadata": {}, "score": "49.31269"}
{"text": "The authors declare no conflict of interest .References .Kidney Int .[ Google Scholar ] [ CrossRef ] .Pitts , T.O. ; Piraino , B.H. ; Mitro , R. ; Chen , T.C. ; Segre , G.V. ; Greenberg , A. ; Puschett , J.B. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild , moderate , and severe renal failure .", "label": "", "metadata": {}, "score": "49.39154"}
{"text": "The purpose of the present study was to investigate the effectiveness of cinacalcet - based vs. vitamin D based regimen in treating SHPT , achieving the K / DOQI targets for PD patients , and the cinacalcet effect on FGF23 suppression .", "label": "", "metadata": {}, "score": "49.39685"}
{"text": "AMG 416 was also evaluated in a rat model of chronic kidney disease ( the 5/6 nephrectomy model or 5/6 Nx ) , a commonly used model of CKD - MBD that enables chronic dosing [ 9 ] .", "label": "", "metadata": {}, "score": "49.599865"}
{"text": "Cinacalcet treatment ( 10 mg / kg ) in the same model resulted in acutely lowered plasma PTH levels which returned to placebo levels by 24 hours post - dose .", "label": "", "metadata": {}, "score": "49.67331"}
{"text": "J. Nephrol .[ Google Scholar ] [ CrossRef ] .Antonsen , J.E. ; Sherrard , D.J. ; Andress , D.L. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure .", "label": "", "metadata": {}, "score": "49.71165"}
{"text": "These conflicting results , far from being conclusive , underline the need for gaining further information on this critical issue .Another point of potential concern is the possible interference of cinacalcet with the immune - suppressive ( IS ) drugs and its potential effect on the graft function .", "label": "", "metadata": {}, "score": "50.020916"}
{"text": "On multivariate analysis , the use of cinacalcet was not a predictor for PTH within KDIGO guidelines at 2-year follow - up .Conclusion : Cinacalcet was used in the majority ( 67 % ) of patients on chronic dialysis with secondary hyperparathyroidism , but the use of cinacalcet did not affect mean PTH values nor the proportion of patients following KDIGO guidelines compared with patients not using calcimimetics .", "label": "", "metadata": {}, "score": "50.070637"}
{"text": "N. Engl .J. Med .[ Google Scholar ] [ CrossRef ] .Block , G.A. ; Zaun , D. ; Smits , G. ; Persky , M. ; Brillhart , S. ; Nieman , K. ; Liu , J. ; St Peter , W.L. Cinacalcet hydrochloride treatment significantly improved all - cause and cardiovascular survival in a large cohort of hemodialysis patients .", "label": "", "metadata": {}, "score": "50.242607"}
{"text": "In addition , AMG 416 offers the potential for improved gastrointestinal tolerability over cinacalcet [ 3 , 17 ] , and because it is not metabolized by the liver and does not interact with P450 enzymes [ 17 ] , avoids the risk of P450-mediated drug - drug interactions .", "label": "", "metadata": {}, "score": "50.248886"}
{"text": "12 , pp .2305 - 2314 , 2010 .View at Google Scholar . A. L. Serra , R. Savoca , A. R. Huber et al . , \" Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "50.26495"}
{"text": "Reinforcing this view , recent papers observed a regression of parathyroid gland volume , as assessed by US methodology , in KTx patients treated with a calcimimetic drug [ 56 , 57 ] .", "label": "", "metadata": {}, "score": "50.506134"}
{"text": "At variance with these results , other AA [ 36 ] , though confirming that calcium deposits are frequently found ( 44 % ) in transplanted kidney biopsies , were not able to find any relationship between nephrocalcinosis and serum calcium levels .", "label": "", "metadata": {}, "score": "50.665165"}
{"text": "STUDY DESIGN :Open - label prospective uncontrolled trial .SETTING & PARTICIPANTS : 10 stable kidney transplant recipients with persistent hyperparathyroidism .INTERVENTION : Cinacalcet , 30 and 60 mg / d , for 2 weeks .", "label": "", "metadata": {}, "score": "50.69908"}
{"text": "A stronger design would have been to compare PTX rates in patients receiving cinacalcet with rates in patients who did not .However , in the absence of available PTH levels , it was not possible to identify a control group that would have had the same severity of hyperparathyroidism and did not receive cinacalcet .", "label": "", "metadata": {}, "score": "50.73631"}
{"text": "Forty - eight hours after surgery , animals were administered a single IV bolus of AMG 416 ( 0.5 mg / kg ) , saline or a single po dose of cinacalcet ( 30 mg / kg ) .", "label": "", "metadata": {}, "score": "50.99749"}
{"text": "None declared .References 1 .Uren \u02dc a P , Basile C , Grateau G et al .Short - term effects of parathyroidectomy on plasma biochemistry in chronic uremia .", "label": "", "metadata": {}, "score": "51.081146"}
{"text": "In order to ensure prescriptions were being fulfilled , two dispensations were requested for each patient .The average daily dose for selected medication was calculated including : calcium - containing binders , sevelamer , lanthanum , alfacalcidol , calcitriol , and cinacalcet .", "label": "", "metadata": {}, "score": "51.297447"}
{"text": "Acid - base status was unchanged .LIMITATIONS :This is a small study and does not examine the long - term effect of cinacalcet treatment .", "label": "", "metadata": {}, "score": "51.38246"}
{"text": "Serum levels of albumin , iPTH , calcium ( Ca ) , phosphate ( P ) and alkaline phosphatase were deter- mined monthly .The treatment group included four cases of nodular hyperplasia and two cases of car- cinoma of parathyroid glands , whereas the control group included four cases of nodular hyperplasia and two cases of diffuse hyperplasia .", "label": "", "metadata": {}, "score": "51.56158"}
{"text": "One hypothesis that could explain these difficulties is that dialysis population with SHPT is not homogeneous .Multiple correspondence analysis and ascendant hierarchical clustering on clinico - biological ( symptoms , PTH , plasma phosphorus and alkaline phosphatase ) and treatment of SHPT ( cinacalcet , vitamin D , calcium , or calcium - free calcic phosphate binder ) were performed to identify distinct phenotypes .", "label": "", "metadata": {}, "score": "51.611618"}
{"text": "The present study might suggest a more direct association between serum FGF23 and cinacalcet treatment , independent from other mineral metabolic parameters and vitamin D dose .", "label": "", "metadata": {}, "score": "51.6903"}
{"text": "5 , pp .675 - 680 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. R. Srinivas , J. D. Schold , K. L. Womer et al . , \" Improvement in hypercalcemia with cinacalcet after kidney transplantation , \" Clinical Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "51.762276"}
{"text": "6 , pp .662 - 670 , 1982 .View at Google Scholar \u00b7 View at Scopus .M. Rodriguez , A. Martin - Malo , M. E. Martinez , A. Torres , A. J. Felsenfeld , and F. Llach , \" Calcemic response to parathyroid hormone in renal failure : role of phosphorus and its effect on calcitriol , \" Kidney International , vol .", "label": "", "metadata": {}, "score": "51.895325"}
{"text": "This data shows a clear shift to lower dosing of calcium - based binders and an increasing utilization of non - calcium - based binders such as sevelamer and lanthanum .", "label": "", "metadata": {}, "score": "52.156757"}
{"text": "Lindberg JS , Culleton B , Wong G et al .Cinacalcet HCl , an oral calcimimetic agent for the treatment of secondary hyper- parathyroidism in hemodialysis and peritoneal dialysis : A randomized , double - blind , Nephrol 2005 ; 16 : 800 - 807 13 .", "label": "", "metadata": {}, "score": "52.296097"}
{"text": "On the contrary , the proportion of patients using sevelamer increased until 2005 then remained fairly stable .The average daily dose of sevelamer followed the same pattern of use .", "label": "", "metadata": {}, "score": "52.38227"}
{"text": "Furthermore , although hypocalcemia is not uncommon during cinacalcet management , the present study identified that incidence of hypocalcemia was comparable between combined therapy and calcitriol alone .", "label": "", "metadata": {}, "score": "52.42005"}
{"text": "Therefore , one could postulate that the suppression of FGF23 in the cinacalcet group may be associated with lower exposure to vitamin D and lower level of PTH .", "label": "", "metadata": {}, "score": "52.741684"}
{"text": "Because severe secondary hyperparathyroidism may not be completely controlled in all patients using cinacalcet and because some patients may not tolerate cinacalcet or would prefer to undergo a PTX , it is expected that rates of PTX would not fall indefinitely .", "label": "", "metadata": {}, "score": "52.929436"}
{"text": "There is some evidence that calcineurin inhibitors ( CNIs ) , in particular cyclosporine , might increase bone resorption and thus potentially promote the development of HC [ 25 ] .", "label": "", "metadata": {}, "score": "53.154167"}
{"text": "The average parathyroidectomy rate before cinacalcet availability was 11.4 /1000 person - years , and 3.6 /1000 person - years after cinacalcet public formulary listing .", "label": "", "metadata": {}, "score": "53.19635"}
{"text": "Our results are consistent with a pooled analysis of short duration trials that showed a reduce incidence of PTX with cinacalcet ( from 41 /1000p - y in the placebo group to 3 /1000 p - y in the cinacalcet group ) [ 3 ] .", "label": "", "metadata": {}, "score": "53.260193"}
{"text": "Nephrol .Dial .Transplant .[ Google Scholar ] [ CrossRef ] .Palmer , S.C. ; McGregor , D.O. ; Macaskill , P. ; Craig , J.C. ; Elder , G.J. ; Strippoli , G.F. Meta - Analysis : Vitamin D compounds in chronic kidney disease .", "label": "", "metadata": {}, "score": "53.523636"}
{"text": "The aim was to limit hypocalcaemia induced by cinacalcet by maximizing the transfer of Ca ions from the dialysate to the blood , as recommended also by the NKF / K - DOQI guidelines [ 9].", "label": "", "metadata": {}, "score": "53.528503"}
{"text": "Borchhardt KA , Heinzl H , Mayerwoger E , Horl WH , Haas M , Sunder - Plassmann G : Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation .", "label": "", "metadata": {}, "score": "53.575127"}
{"text": "Moe SM , Chertow GM , Coburn JW et al .Achieving NKF - K/ DOQI bone metabolism and disease treatment goals with cinacalcet HCl .", "label": "", "metadata": {}, "score": "53.646675"}
{"text": "Some years ago , Nankivell et al .[ 31 ] pointed out that microcalcifications were a common finding in protocol biopsies performed in transplanted kidneys , since they were observed in 43 % and 79 % of biopsies at 1 year and 10 years after KTx , respectively .", "label": "", "metadata": {}, "score": "53.69796"}
{"text": "Cinacalcet treatment was independently associated with FGF23 reduction , after adjustment to the age and sex .One could postulate that cinacalcet per se might have a modulatory effect on the FGF23 level .", "label": "", "metadata": {}, "score": "53.835068"}
{"text": "B. A. Julian , D. A. Laskow , J. Dubovsky , E. V. Dubovsky , J. J. Curtis , and L. D. Quarles , \" Rapid loss of vertebral mineral density after renal transplantation , \" New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "54.12255"}
{"text": "According to Amgen internal data , 4 patients received cinacalcet through this program in 2004 , 40 in 2005 , and 58 in 2006 .Some private insurance companies may have reimbursed cinacalcet for patients not covered by the provincial RAMQ drug plan .", "label": "", "metadata": {}, "score": "54.148827"}
{"text": "Higher dose pharmacological use of vitamin D therapy through the activation of VDR has demonstrated its efficacy in suppressing hyperparathyroidism and several large observational studies have also shown survival advantage [ 10 , 11 , 12 ] .", "label": "", "metadata": {}, "score": "54.196735"}
{"text": "Colloton M , Shatzen E , Miller G , Stehman - Breen C , Wada M , Lacey D , Martin D : Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism .", "label": "", "metadata": {}, "score": "54.2528"}
{"text": "Patients who had been taking azole antifungal agents , macrolide antibiotics , amiodarone , tricyclic antidepressant , vinca alkaloid , bupropion antipsychotics , calcitonin , biosphosphonate , steroid hormones , or benzodiazepine drugs were excluded .", "label": "", "metadata": {}, "score": "54.25319"}
{"text": "Introduction .Though kidney transplant ( KTx ) might induce a regression of most metabolic derangements characterizing end - stage renal disease ( ESRD ) , electrolyte disturbances are not uncommonly encountered in patients with an even well - functioning renal graft .", "label": "", "metadata": {}, "score": "54.29368"}
{"text": "As with most retrospective studies using dispensed medications , there is uncertainty with patient compliance .In addition , intravenous vitamin D analogue claims are not captured within the RAMQ database , since vitamin D analogues are dispensed by the dialysis unit and a claim would not be submitted by the patient to the RAMQ .", "label": "", "metadata": {}, "score": "54.401108"}
{"text": "Furthermore , this therapy is associated with improvement in hyperphosphatemia and hypercalcemia .Keywords : . cinacalcet ; uremic hyperparathyroidism ; dialysis ; parathyroid hormone .", "label": "", "metadata": {}, "score": "54.469734"}
{"text": "The specific prescription for the cinacalcet group was adjusted according to the treatment algorithm ( Figure 1 ) .No subjects had ever taken cinacalcet before screening since cinacalcet was not available in Korea at the time of the study .", "label": "", "metadata": {}, "score": "54.66497"}
{"text": "Soc .Nephrol .[ Google Scholar ] .Ross , E.A. ; Tian , J. ; Abboud , H. ; Hippensteel , R. ; Melnick , J.Z. ; Pradhan , R.S. ; Williams , L.A. ; Hamm , L.L. ; Sprague , S.M. Oral paricalcitol for the treatment of secondary hyperparathyroidism on hemodialysis or peritoneal dialysis .", "label": "", "metadata": {}, "score": "54.909378"}
{"text": "363 - 370 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Meola , I. Petrucci , and G. Barsotti , \" Long - term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "54.96004"}
{"text": "Finally , medication use among patients covered by private drug plans who are generally younger patients ( an important risk factor for severe secondary hyperparathyroidism ) could not be assessed .", "label": "", "metadata": {}, "score": "54.969433"}
{"text": "J Am Soc Nephrol 2003 ; 14 : 575 - 583 11 .Block GA , Martin KJ , de Francisco AL et al .Cinacalcet for secondary hyperparathyroidism in patients receving hemo- dialysis .", "label": "", "metadata": {}, "score": "55.095936"}
{"text": "For both , the average daily dose increased slowly with time .Use of magnesium or aluminium - containing binders was negligible .Trends in selected medication use .", "label": "", "metadata": {}, "score": "55.098488"}
{"text": "5 , pp .546 - 549 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Bergua , J. V. Torregrosa , D. Fuster , A. Gutierrez - Dalmau , F. Oppenheimer , and J. M. Campistol , \" Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "55.158337"}
{"text": "Cinacalcet is a novel agent that increases sensitivity to the calcium - sensing receptor and is approved for control of UHPT .Nevertheless , cinacalcet is costly and information regarding efficacy of low - dose cinacalcet on UHPT is limited .", "label": "", "metadata": {}, "score": "55.231346"}
{"text": "[ 13 ] allowed relatively constant dosage of vitamin D during the study period .Since the dosage of vitamin D was allowed to be titrated according to the biochemical parameters in the present study , the cinacalcet group was prescribed with lower dose of vitamin D than the control group .", "label": "", "metadata": {}, "score": "55.2555"}
{"text": "AMG 416 was administered as a single intravenous ( IV ) bolus in a severe , acute model of renal insufficiency ( the \" 1K1C \" model ) and plasma parathyroid hormone ( PTH ) and serum calcium levels were monitored for 24 hours .", "label": "", "metadata": {}, "score": "55.26025"}
{"text": "Kidney Int 2005 ; 67 : 467 - 476 23 .Kawata T , Imanishi Y , Kobayashi K et al .Direct in vitro evidence of the suppressive effect of cinacalcet HCl on para- thyroid hormone secretion in human parathyroid cells with pathologically reduced calcium - sensing receptor levels .", "label": "", "metadata": {}, "score": "55.356346"}
{"text": "Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism .Nephrol Dial Transplant 2005 ; 20 : 1315 - 1319 19 .", "label": "", "metadata": {}, "score": "55.412125"}
{"text": "It therefore indicates that combined therapy may reduce the use of aluminum hydroxide and lower the risk of aluminum toxicity in dialysis patients .Limitations of the Study .", "label": "", "metadata": {}, "score": "55.4489"}
{"text": "This variability might be at least in part dependent on the time when the assessment was performed .With ongoing treatment , these effects can be counteracted by the reduced glomerular filtered calcium load , secondary to the reduction of serum calcium levels which eventually bring its urinary excretion back to the pretreatment levels .", "label": "", "metadata": {}, "score": "55.55424"}
{"text": "6 , pp .1713 - 1720 , 1994 .View at Google Scholar \u00b7 View at Scopus . D. A. McCarron , R. S. Muther , B. Lenfesty , and W. M. Bennett , \" Parathyroid function in persistent hyperparathyroidism : relationship to gland size , \" Kidney International , vol .", "label": "", "metadata": {}, "score": "55.57142"}
{"text": "We report the results of the efficacy of the calcimimetic cinacalcet in six hemodialysis ( HD ) and three peritoneal dialysis ( PD ) pediatric patients with HTBD , age 14.5 + /- 1.0 ( range 7.5 - 17.5 ) years .", "label": "", "metadata": {}, "score": "55.579975"}
{"text": "The second one is defined microscopic nephrocalcinosis , characterized by smaller calcium salt depositions at the tubular cell and/or the interstitial space level and can be detected only by microscopic examination .", "label": "", "metadata": {}, "score": "55.6362"}
{"text": "The latter does not appear to be able to control these forms ; furthermore , the risk of inducing hypercalcaemia and/or hyperphosphataemia with theconventionaltreatment unavoidable therapeutic discontinuity , which repre- sents a further limit to the efficacy of the conventional treatment .", "label": "", "metadata": {}, "score": "55.770016"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable . \" In some cases , Lomonte et al . have described the successful use of cinacalcet inducing the suppression of intact PTH secretion by the parathyroid glands [ 20].", "label": "", "metadata": {}, "score": "55.8546"}
{"text": "Background .Elevated serum level of fibroblast growth factor-23 ( FGF23 ) is associated with adverse outcomes in dialyzed patients .Objectives .The CUPID study compared the efficacy of a cinacalcet - based regimen with conventional care ( vitamin D and P binders ) for achieving the stringent NKF - K / DOQI targets for peritoneal dialysis ( PD ) patients .", "label": "", "metadata": {}, "score": "55.87383"}
{"text": "PubMed View Article .Block GA , Hulbert - Shearon TE , Levin NW , Port FK : Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients : a national study .", "label": "", "metadata": {}, "score": "55.88807"}
{"text": "For early - stage UHPT , it has been recognized that conventional management with dietary phosphorus restriction , phosphate binder and active vitamin D has distinct efficacy on renal osteodystrophy and additional important health benefits [ 10 , 20 ] .", "label": "", "metadata": {}, "score": "55.97467"}
{"text": "However , the present study exhibited that serum FGF23 was significantly reduced during cinacalcet treatment .Moreover , cinacalcet effect on the FGF23 suppression was independent of its effect on serum iPTH , Ca , P , and the exposure to oral vitamin D. .", "label": "", "metadata": {}, "score": "56.04586"}
{"text": "Summarizing , though we have no conclusive evidence that HC can be responsible for the nephrocalcinosis , which is frequently observed in kidney graft biopsies , there are plausible reasons for thinking that persistently high serum calcium levels might adversely affect kidney graft outcome .", "label": "", "metadata": {}, "score": "56.054085"}
{"text": "Due to mortality during the study , group sizes for PTH and Ca analysis were 7 , 6 and 9 for saline , cinacalcet and AMG 416 , respectively .", "label": "", "metadata": {}, "score": "56.1521"}
{"text": "Renal replacement therapy .PTX : .Parathyroidectomy .sHPT : .Seconcary hyperparathyroidism .SRR : .Swedish renal registry .SNIR : .Swedish national inpatient registry .", "label": "", "metadata": {}, "score": "56.218216"}
{"text": "544 - 550 , 1991 .View at Google Scholar \u00b7 View at Scopus . S. Giannini , A. D'Angelo , M. Nobile , et al . , \" The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation , \" Journal of Bone and Mineral Research , vol .", "label": "", "metadata": {}, "score": "56.34273"}
{"text": "The right kidney was removed following ligation of the right renal pedicle and ureter .A microvascular clip was applied to the left renal artery for 45 min and then removed .", "label": "", "metadata": {}, "score": "56.35991"}
{"text": "Some years ago , it was first reported that the maximal PTH response to a hypocalcemic challenge , which is considered a good marker of the functional parathyroid gland mass , substantially reduced from the 1st to the 6th month after renal transplantation [ 54 ] .", "label": "", "metadata": {}, "score": "56.423153"}
{"text": "The treatment group included four cases of nodular hyperplasia and two cases of carcinoma of parathyroid glands , whereas the control group included four cases of nodular hyperplasia and two cases of diffuse hyperplasia .", "label": "", "metadata": {}, "score": "56.451393"}
{"text": "Taken together , these findings demonstrate that AMG 416 suppresses plasma PTH and is a potential new therapy for the treatment of CKD patients with SHPT receiving hemodialysis .", "label": "", "metadata": {}, "score": "56.4786"}
{"text": "Figure 1 .Figure 2 .Figure 2 .The Use and Dosage of Phosphate Binder and Calcitriol .The usage of of phosphate binder and calcitriol during treatment period is summarized in Table 3 .", "label": "", "metadata": {}, "score": "56.69764"}
{"text": "There are a number of endpoints that can be examined in preclinical models of SHPT such as effects on PTH , serum phosphorus and calcium levels and parathyroid gland hyperplasia .", "label": "", "metadata": {}, "score": "56.714123"}
{"text": "421 - 427 , 2011 .View at Google Scholar . U.Thiem , G. Heinze , R. Segel et al . , \" K. VITA - D : cholecalciferol substitution in vitamin D deficient kidney transplant recipients : a randomized , placebo - controlled study to evaluate the post - transplant outcome , \" Trials , vol .", "label": "", "metadata": {}, "score": "56.760864"}
{"text": "Notably , calcitriol was introduced in patients 1 , 2 , 3 and 4 because these patients had previously , and continued to have , serum Ca levels below the lower limits advised by the NKF / K - DOQI guidelines [ 9].", "label": "", "metadata": {}, "score": "56.930344"}
{"text": "1048 - 1053 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. A. Borchhardt , D. Diarra , I. Sulzbacher , T. Benesch , M. Haas , and G. Sunder - Plassmann , \" Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation , \" American Journal of Nephrology , vol .", "label": "", "metadata": {}, "score": "56.93872"}
{"text": "The phosphatemic effects of cinacalcet correlated with a marked decrease in the phosphaturic hormone PTH , rather than with a change in FGF-23 levels or acid - base status , highlighting the importance of PTH in posttransplantation hypophosphatemia .", "label": "", "metadata": {}, "score": "57.02448"}
{"text": "An increase in medical satellite unit hemodialysis but a decrease in self - care unit hemodialysis rates were noticed across the time , whereas peritoneal dialysis remained stable at 7 % .", "label": "", "metadata": {}, "score": "57.051548"}
{"text": "However , some recent studies seem to minimize this concern , since no relevant adverse event related to HC episodes have been reported in KTx patients treated with cholecalciferol [ 71 , 72 ] .", "label": "", "metadata": {}, "score": "57.068123"}
{"text": "There were no significant differences in both groups .Other adverse reactions in the cinacalcet group were tingling sensation ( 6.1 % ) , general weakness ( 3.0 % ) , and headache ( 6.1 % ) .", "label": "", "metadata": {}, "score": "57.08623"}
{"text": "Two decades ago , Frick et al .[50 ] , studying 224 consecutive KTx patients , reported 8 patients who experienced an acute pancreatitis episode and 20 patients who had an asymptomatic increase of serum pancreatic enzymes .", "label": "", "metadata": {}, "score": "57.09375"}
{"text": "A case report reviewed 12 patients with parathyroid carcinoma who were receiving mainte- nance haemodialysis [ 24].All demonstrated hyper- plasia of other parathyroid glands .", "label": "", "metadata": {}, "score": "57.29505"}
{"text": "N Engl J Med 2004 , 350 ( 15 ) : 1516 - 1525 .PubMed View Article .Cunningham J , Danese M , Olson K , Klassen P , Chertow GM : Effects of the calcimimetic cinacalcet HCl on cardiovascular disease , fracture , and health - related quality of life in secondary hyperparathyroidism .", "label": "", "metadata": {}, "score": "57.30793"}
{"text": "Abstract .Background .Recent trends in parathyroidectomy rates are not known .Our objective was to investigate the trend in parathyroidectomy rates between 2001 and 2010 , and to evaluate if the availability and reimbursement of cinacalcet modified that trend .", "label": "", "metadata": {}, "score": "57.351883"}
{"text": "Furthermore , recently some AA reported that posttransplant erythrocytosis is 2 - 3 times more frequent in KTx patients who have higher serum calcium levels as compared with normocalcemic patients [ 47 , 48 ] .", "label": "", "metadata": {}, "score": "57.394096"}
{"text": "1315 - 1319 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Falck , N. T. Vethe , A. \u00c5sberg et al . , \" Cinacalcet 's effect on the pharmacokinetics of tacrolimus , cyclosporine and mycophenolate in renal transplant recipients , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "57.486877"}
{"text": "PubMed .Block GA , Hulbert - Shearon TE , Levin NW , Port FK : Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients : a national study .", "label": "", "metadata": {}, "score": "57.616642"}
{"text": "For all these reasons , the recent availability of a medical approach to hypercalcemic PT - HPT based on the use of cinacalcet challenged the concept of considering PTX the best choice for this clinical condition .", "label": "", "metadata": {}, "score": "57.627235"}
{"text": "For cinacalcet to be reimbursed for a given patient , the prescriber would need to obtain a prior authorization from the provincial drug plan by filling a form detailing those criteria .", "label": "", "metadata": {}, "score": "57.71826"}
{"text": "Intern .Med .[ Google Scholar ] .Goodman , W.G. ; Frazao , J.M. ; Goodkin , D.A. ; Turner , S.A. ; Liu , W. ; Coburn , J.W. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism .", "label": "", "metadata": {}, "score": "57.72264"}
{"text": "View Article .Slinin Y , Foley RN , Collins AJ : Clinical epidemiology of parathyroidectomy in hemodialysis patients : the USRDS waves 1 , 3 , and 4 study .", "label": "", "metadata": {}, "score": "57.738205"}
{"text": "Cinacalcet is an allosteric modulator of the CaSR that sensitizes the receptor to extracellular calcium , resulting in reduced PTH secretion from the parathyroid gland [ 4 ] .", "label": "", "metadata": {}, "score": "57.75438"}
{"text": "Patients at high risk should receive immunosuppressive therapy ( IS ) .Seventy - four biopsy - proven MNi were diagnosed with 50 nephrotic ( 22 Before and 28 After ) of which 20 had normal renal function .", "label": "", "metadata": {}, "score": "57.784092"}
{"text": "11 , pp .2515 - 2521 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. H. Saha , K. T. Salmela , P. J. Ahonen et al . , \" Sequential changes in vitamin D and calcium metabolism after successful renal transplantation , \" Scandinavian Journal of Urology and Nephrology , vol .", "label": "", "metadata": {}, "score": "57.792152"}
{"text": "This is to be expected , given that renal transplantation usually ameliorates sHPT [ 11 ] .In the present study the overall unadjusted PTX rate was 8.8 ( 95 % CI , 8.1 - 9.4 ) per 1000 person - years , which is in line with previous investigations , reporting an incidence between 4.3 and 15.2/1000 person - years [ 1 - 5 , 12 ] .", "label": "", "metadata": {}, "score": "57.998062"}
{"text": "982 - 989 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Komaba , S. Nakanishi , A. Fujimori , et al . , \" Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism , \" Clinical Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "58.079132"}
{"text": "Animals were dosed daily for 28 days .Serum creatinine levels were also increased with group mean values of 1.4 , 1.3 and 1.3 mg / dL for the saline , cinacalcet and AMG 416 groups , respectively .", "label": "", "metadata": {}, "score": "58.09736"}
{"text": "Methods .From the Swedish Renal Registry we extracted data on 20 015 patients on RRT between 1991 and 2009 .In these , 679 incident PTX ( 3.4 % ) were identified by linkage with the National Inpatient Registry , and the Scandinavian Quality Registry for Thyroid Parathyroid and Adrenal Surgery .", "label": "", "metadata": {}, "score": "58.11129"}
{"text": "PubMed View Article .Henley C , Colloton M , Cattley RC , Shatzen E , Towler DA , Lacey D , Martin D : 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl ( Sensipar / Mimpara ) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism .", "label": "", "metadata": {}, "score": "58.167885"}
{"text": "The control group received flexible dose of oral active vitamin D to achieve K / DOQI targets for PTH , Ca , P , and Ca \u00d7 P. For active vitamin D , only oral calcitriol , not active vitamin D analogs , was prescribed for both groups .", "label": "", "metadata": {}, "score": "58.216858"}
{"text": "Despite not being widely available before June 2006 , carefully selected patients could have received cinacalcet from Amgen or private insurance companies .In the context where cinacalcet was probably given to patients who would otherwise have undergone a PTX and because the annual counts of PTX ranged from 29 to 57 before 2005 , only a few patients receiving cinacalcet could have highly influenced the observed PTX rates .", "label": "", "metadata": {}, "score": "58.235428"}
{"text": "or oral or paricalcitol i.v .at the end of the dialysis session ) .Study procedures Serum levels of albumin , iPTH , Ca , P and alkaline phos- phatase ( ALP ) were determined monthly 12h after the administrationof cinacalcet . albumin , Ca , P and ALP were measured by routine automated methods .", "label": "", "metadata": {}, "score": "58.240814"}
{"text": "However , it is speculated that wider availability of cinacalcet through reimbursement in Qu\u00e9bec may be a factor .The higher PTX rates observed here among prevalent and younger patients are consistent with previous studies and with the physiopathology of secondary hyperparathyroidism [ 5 , 20 ] .", "label": "", "metadata": {}, "score": "58.27612"}
{"text": "10 , pp .1653 - 1659 , 1993 .View at Google Scholar \u00b7 View at Scopus .R. S. Gaston , B. A. Julian , C. V. Barker , A. G. Diethelm , and J. J. Curtis , \" Enalapril : safe and effective therapy for posttransplant erythrocytosis , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "58.2864"}
{"text": "In fact a recent paper demonstrated that some polymorphic variants of the CaSR gene might play some role in the different urinary calcium excretion found in primary hyperparathyroid patients with or without nephrolithiasis [ 70 ] .", "label": "", "metadata": {}, "score": "58.48902"}
{"text": "Martin KJ , Bell G , Pickthorn K , Huang S , Hodsman P , Peacock M : Characterization of KAI-4169 , a novel peptide for the treatment of chronic kidney disease - mineral and bone disorder , in a phase 1 study in healthy males .", "label": "", "metadata": {}, "score": "58.48906"}
{"text": "Meanwhile , as described in our previous study , the disturbance of bone mineral metabolism was associated with chronic inflammation in chronic dialysis patients [ 6 ] .", "label": "", "metadata": {}, "score": "58.586662"}
{"text": "Kawata T , Nagano N , Obi M , Miyata S , Koyama C , Kobayashi N , Wakita S , Wada M : Cinacalcet suppresses calcification of the aorta and heart in uremic rats .", "label": "", "metadata": {}, "score": "58.627846"}
{"text": "1151 - 1157 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Ko\u00e7 , A. Bihorac , C. I. Ozener , G. Kantarci , and E. Akoglu , \" Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim - sulfamethoxazole , \" American Journal of Kidney Diseases , vol .", "label": "", "metadata": {}, "score": "58.714657"}
{"text": "Calcimimetic agent , such as cinacalcet , which not only allosterically enhances sensitivity to CaSR , but also increases the expression of VDR of the parathyroid gland , became available since its approval in 2004 [ 14 ] .", "label": "", "metadata": {}, "score": "58.727783"}
{"text": "Goodman WG .Recent developments in the management of secondary hyperparathyroidism .Kidney Int 2001 ; 59 : 1187 - 1201 6 .Silver J. Pathogenesis of parathyroid dysfunction in end - stage renal disease .", "label": "", "metadata": {}, "score": "58.740707"}
{"text": "The presence of persistently elevated serum calcium concentrations , associated with elevated PTH levels , has for some time been considered a possible indication to parathyroidectomy ( PTX ) in KTx patients .", "label": "", "metadata": {}, "score": "58.770966"}
{"text": "The prolonged suppression of plasma PTH in the 1K1C model by AMG 416 is consistent with the pharmacokinetics ( PK ) observed for AMG 416 in normal rats and in different uremic models [ 5 ] .", "label": "", "metadata": {}, "score": "58.87072"}
{"text": "This combination therapy is associated with improvement in hyperphosphatemia and hypercalcemia .Furthermore , there was a significant decrease in the usage and dosage of aluminum hydroxide in combination therapy at the end of the treatment period .", "label": "", "metadata": {}, "score": "58.923203"}
{"text": "AMG 416 has also proven effective in clinical studies in both normal healthy males and CKD patients with SHPT receiving hemodialysis [ 6 , 7 ] .", "label": "", "metadata": {}, "score": "58.977516"}
{"text": "Animals treated with vehicle showed no reduction in PTH during the study .AMG 416 administration lowers PTH in a severe model of kidney dysfunction .", "label": "", "metadata": {}, "score": "58.987347"}
{"text": "View Article .Koizumi M , Komaba H , Nakanishi S , Fujimori A , Fukagawa M : Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism .", "label": "", "metadata": {}, "score": "58.994453"}
{"text": "Figure 1 : The main supposed mechanisms responsible for the occurrence of hypercalcemia after kidney transplant .( Pi : inorganic phosphorus ; CNI : calcineurin inhibitors ; RAPA : rapamycin ; FGF23 : fibroblast growth factor 23 ) .", "label": "", "metadata": {}, "score": "59.103996"}
{"text": "Rates of PTX varied considerably between 1992 and 2007 [ 5 - 8 ] .These fluctuations were attributed to availability of new therapeutic options ( vitamin D analogs and non - calcium - containing phosphate binders ) and publication of practice guidelines [ 5 ] .", "label": "", "metadata": {}, "score": "59.158043"}
{"text": "Whether cinacalcet directly acts on the CaSR at the bone cells to regulate FGF23 secretion needs to be investigated .The strengths of this study include prospective , randomized study and a design to follow change of FGF23 levels in PD patients with cinacalcet treatment , compared with conventional vitamin D treatment .", "label": "", "metadata": {}, "score": "59.170235"}
{"text": "Serum creatinine levels ( mg / dL ) for the three groups were : AMG 416 ( 5.5 ) , cinacalcet ( 5.1 ) , saline ( 6.1 ) .", "label": "", "metadata": {}, "score": "59.289543"}
{"text": "To date , several studies reported that cinacalcet reduced FGF23 in predialysis or hemodialysis patients [ 12 , 13 ] .It was shown that FGF23 levels are independently correlated with serum concentrations of P , Ca x P , and serum parathyroid hormones ( PTH ) .", "label": "", "metadata": {}, "score": "59.365887"}
{"text": "PubMed View Article .Kestenbaum B , Seliger SL , Gillen DL , Wasse H , Young B , Sherrard DJ , Weiss NS , Stehman - Breen CO : Parathyroidectomy rates among United States dialysis patients : 1990 - 1999 .", "label": "", "metadata": {}, "score": "59.382637"}
{"text": "Srinivas TR , Schold JD , Womer KL et al .Improvement in hypercalcemia with cinacalcet after kidney transplantation .Cl J Am Soc Nephrol 2006 ; 1 : 323 - 326 21 .", "label": "", "metadata": {}, "score": "59.43193"}
{"text": "Moe SM , Cunningham J , Bommer J et al .Long - term treatment of secondary hyperparathyroidism with the calcimi- metic cinacalcet HCl .Nephrol Dial Transplant 2005 ; 20 : 2186 - 2193 9 .", "label": "", "metadata": {}, "score": "59.48844"}
{"text": "6 , pp .646 - 651 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. E. Kruse , U. Eisenberger , F. J. Frey , and M. G. Mohaupt , \" The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "59.523895"}
{"text": "The calcimimetic cinacalcet normalizes serum calcium in renal transplantpatientswith Nephrol Dial Transplant 2005 ; 20 : 1311 - 1314 multicenterstudy .J Am Soc cinacalcetHClon persistenthyperparathyroidism .", "label": "", "metadata": {}, "score": "59.800285"}
{"text": "Wetmore JB , Liu S , Krebill R , Menard R , Quarles LD : Effects of cinacalcet and concurrent low - dose vitamin D on FGF23 levels in ESRD .", "label": "", "metadata": {}, "score": "59.886993"}
{"text": "An important point is that , however , two out of these patients were non - responders : we hypothesize that this might be due to the loss of CaSR in parathyroid carcinoma and in part of parathyroid nodular hyperplasia .", "label": "", "metadata": {}, "score": "59.960857"}
{"text": "PubMed Central PubMed View Article .Bonarek H , Merville P , Bonarek M , Moreau K , Morel D , Aparicio M , Potaux L : Reduced parathyroid functional mass after successful kidney transplantation .", "label": "", "metadata": {}, "score": "60.027153"}
{"text": "Retrospective analysis of all subjects enrolled in the GRAGIL-1c and GRAGIL-2 islet transplantation trials .Parameters related to metabolic control , graft function , and safety outcomes were studied .", "label": "", "metadata": {}, "score": "60.05239"}
{"text": "2085 - 2092 , 2010 .View at Google Scholar .P. Messa , C. Vallone , G. Mioni et al . , \" Direct in vivo assessment of parathyroid hormone - calcium relationship curve in renal patients , \" Kidney International , vol .", "label": "", "metadata": {}, "score": "60.175617"}
{"text": "6 , pp .1730 - 1737 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Taniguchi , M. Tokumoto , D. Matsuo et al . , \" Persistent hyperparathyroidism in renal allograft recipients : vitamin D receptor , calcium - sensing receptor , and apoptosis , \" Kidney International , vol .", "label": "", "metadata": {}, "score": "60.181885"}
{"text": "The dosage of phosphate binder and vitamin D sterols and biochemical data such as corrected serum calcium , phosphorous , iPTH , alkaline phosphatase and hemoglobin were collected and recorded monthly for a successive 6 months before and after commencing UHPT therapy .", "label": "", "metadata": {}, "score": "60.197243"}
{"text": "Dose titration algorithm for cinacalcet and vitamin D in the cinacalcet group during dose - titration period .Initially , cinacalcet group started with 25 mg / day of cinacalcet p.o . and the cinacalcet dose was , in a stepwise pattern , increased at a 4-week interval to 50 mg / day to achieve an iPTH target between 150 and 300 pg / ml .", "label": "", "metadata": {}, "score": "60.238167"}
{"text": "Until June 2013 , we collected retrospectively the prescription of oral anticoagulants and APA , the occurrence of thrombotic or hemorrhagic events .Results : During follow - up , there were 550 events , including 454 thrombotic events and 96 bleeding events .", "label": "", "metadata": {}, "score": "60.27281"}
{"text": "However , the changes in the prevalence of HC over time was also consistently different among the various studies .A fourth possible confounding factor might be a possible different use of vitamin D and/or calcium supplements in the KTx patients .", "label": "", "metadata": {}, "score": "60.316967"}
{"text": "The percentage of patients on vitamin D was stable until 2005 , and then started to rise .The average daily dose of alfacalcidol increased only very slowly however , and calcitriol daily dose remained stable .", "label": "", "metadata": {}, "score": "60.335327"}
{"text": "Genomics 2005 , 15 , 29 - 34 .[ Google Scholar ] [ CrossRef ] .Li , D. ; Shao , L. ; Zhou , H. ; Jiang , W. ; Zhang , W. ; Xu , Y. The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism : A meta - analysis .", "label": "", "metadata": {}, "score": "60.40667"}
{"text": "Table 4 . Rates and incidence rate ratios ( IRR ) of parathyroidectomy per calendar year in the Swedish dialysis and transplant population .Aggregated sales of cinacalcet and yearly rates of PTX/1000 person - years at risk between 2005 and 2009 .", "label": "", "metadata": {}, "score": "60.461536"}
{"text": "When appropriate , one - way ANOVA was used to determine statistical significance with Bonferroni post - test analysis .Serum was obtained by allowing blood samples ( 0.2 - 0.3 mL ) to clot for approximately 30 - 60 minutes followed by centrifugation .", "label": "", "metadata": {}, "score": "60.48236"}
{"text": "Finally , these different results might also be explained by differences among the various transplant centres in the wait - listing policy for the patients with severe SHP .", "label": "", "metadata": {}, "score": "60.499435"}
{"text": "The calcimimetic AMG 073 reduces parathyroid hormone and calciumxpho- sphorus in secondary hyperparathyroidism .Kidney Int 2003 ; 63 : 248 - 254 14 .Basile C , Lomonte C , Vernaglione L et al .", "label": "", "metadata": {}, "score": "60.5082"}
{"text": "323 - 326 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. E. Kruse , U. Eisenberger , F. J. Frey , and M. G. Mohaupt , \" Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "60.678852"}
{"text": "Time between the two periods was not considered in this analysis .As a second sensitivity analysis , ARIMA and Poisson regression analyses were redone by excluding periods of time where patients were not covered by the RAMQ drug plan .", "label": "", "metadata": {}, "score": "60.684048"}
{"text": "View Article .Block GA BG , Pickthorn K , Huang S , Martin KJ : KAI-4169 , a Novel Calcium Sensing Receptor Agonist , Decreses Serum iPTH , FGF-23 and Improves Serum Bone Markers in a Phase 2 Study in Hemodialysis Subjects with Chronic Kidney - Disease - Mineral and Bone Disorder . 49th", "label": "", "metadata": {}, "score": "60.718872"}
{"text": "Effect of cinacalcet on the FGF-23 .Univariate and multivariate linear regression analyses were undertaken to explore factors correlated with the change of FGF23 .After adjustment to age and sex , cinacalcet treatment remained an independent determinant of the serum FGF23 reduction ( Table 3 ) .", "label": "", "metadata": {}, "score": "60.79653"}
{"text": "Hemodial Int 2007 , 11 ( 1 ) : 62 - 71 .PubMed View Article .Daugirdas JT , Finn WF , Emmett M , Chertow GM : The phosphate binder equivalent dose .", "label": "", "metadata": {}, "score": "60.8189"}
{"text": "The major factors responsible for stimulating parathyroid gland function in renal failure involve hyperphosphatemia , hypocalcemia , decreased production of 1,25-dihydroxyvitamin D and peripheral resistance to parathyroid hormone ( PTH ) [ 1 , 2 ] .", "label": "", "metadata": {}, "score": "60.901"}
{"text": "J Am Soc Nephrol 2001 ; 12 : 1242 - 1248 4 .Tominaga Y , Uchida K , Haba T et al .More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism .", "label": "", "metadata": {}, "score": "60.945244"}
{"text": "1311 - 1314 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. L. Serra , A. A. Schwarz , F. H. Wick , H. P. Marti , and R. P. W\u00fcthrich , \" Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "60.966385"}
{"text": "Results : We studied 269 patients .Among the 186 patients who had 2-year follow - up , 125 ( 67 % ) were managed using cinacalcet .", "label": "", "metadata": {}, "score": "60.98812"}
{"text": "Calcimimetics have also shown good therapeutic efficacy in counteracting hypercalcaemia in persistent SHPTH after successful kidney transplan- tation , with a reported variable outcome of renal function [ 18 - 20].", "label": "", "metadata": {}, "score": "61.006264"}
{"text": "Furthermore , some of these patients have already undergone such an intervention and for this or any other reason they may not be prepared to undergo a new intervention .", "label": "", "metadata": {}, "score": "61.018787"}
{"text": "Am .J. Kidney Dis .2003 , 42 , S1-S201 .Kidney Disease : Improving Global Outcomes ( KDIGO ) CKD - MBD Work Group .", "label": "", "metadata": {}, "score": "61.03559"}
{"text": "The only factor which was significantly associated with the pancreatitis episodes was the presence of HC .However , no further paper , as far as we know , has been published in the following decades proving or disproving these findings .", "label": "", "metadata": {}, "score": "61.082935"}
{"text": "Soc .Nephrol .[ Google Scholar ] [ CrossRef ] .Teng , M. ; Wolf , M. ; Lowrie , E. ; Ofsthun , N. ; Lazarus , J.M. ; Thadhani , R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy .", "label": "", "metadata": {}, "score": "61.090652"}
{"text": "The recovered calcitriol levels might concur in inducing HC by both its intestinal and bone effects [ 17 ] .This point might have some therapeutic consequences , as will be discussed more in depth later on .", "label": "", "metadata": {}, "score": "61.107224"}
{"text": "However , above studies have not elucidated whether FGF23 suppression during cinacalcet treatment is mediated indirectly via the modulation of serum P and PTH or directly by cinacalcet per se .", "label": "", "metadata": {}, "score": "61.12583"}
{"text": "Parathyroidectomy ( PTX ) is primarily reserved for symptomatic patients with elevated parathyroid hormone ( PTH ) levels despite optimal medical therapy .While cinacalcet has been shown in trials to reduce PTH levels [ 2 ] and to lower incidence of PTX [ 3 , 4 ] , it remains unclear how availability of this new drug influenced PTX rate trends in a real - world setting .", "label": "", "metadata": {}, "score": "61.14554"}
{"text": "These episodes were treated imme- diately with infusions of Ca gluconate and thereafter by increasing the oral doses of Ca carbonate and/or by adding oral calcitriol to the treatment .", "label": "", "metadata": {}, "score": "61.327255"}
{"text": "Whatever their diabetes status was , patients older than 60 had poor access to the waiting list .Seventeen percent of the patients received a first renal transplant within 15.4 month median time ; 3 % had received a pre - emptive graft .", "label": "", "metadata": {}, "score": "61.329895"}
{"text": "In fact , in our opinion it is questionable to treat KTx patients with normocalcemic PT - HPT with cinacalcet .Conclusions and Opinions .HC after KTx is mainly the terminal event of an evolved and uncontrolled SHP which maybe began long before transplantation .", "label": "", "metadata": {}, "score": "61.341843"}
{"text": "6 , pp .482 - 489 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Vezzoli , A. Scillitani , S. Corbetta , et al . , \" Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism , \" European Journal of Endocrinology , vol .", "label": "", "metadata": {}, "score": "61.504642"}
{"text": "AMG 416 is a novel peptide agonist of the calcium - sensing receptor ( CaSR ) .This report describes the activity of AMG 416 in two different rodent models of uremia , compared in each case to cinacalcet , an approved therapeutic for secondary hyperparathyroidism ( SHPT ) in patients with chronic kidney disease on dialysis .", "label": "", "metadata": {}, "score": "61.560883"}
{"text": "This was presented in various categories and stratified by gender .Poisson regression was used to estimate both unadjusted and adjusted incidence rate ratios .The model was adjusted for calendar year , gender , age , geographical region of treatment , cause of renal disease , and time with functioning graft .", "label": "", "metadata": {}, "score": "61.738205"}
{"text": "21 - 27 , 1994 .View at Google Scholar \u00b7 View at Scopus .P. Evenepoel , M. Naesens , K. Claes , D. Kuypers , and Y. Vanrenterghem , \" Tertiary ' hyperphosphatoninism ' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "61.82697"}
{"text": "Experimental Section .Study Population .In the retrospective study , adult uremic patients those have been receiving chronic dialysis therapy for at least 3 months in our hospital were eligible for screening .", "label": "", "metadata": {}, "score": "61.84931"}
{"text": "Bleeding and thrombosis occurred the most in the APA plus AVK patient group .Events had often recurrences .Patients survived longer in no anticoagulant or antiplatelet group , but with no statistic difference .", "label": "", "metadata": {}, "score": "61.97949"}
{"text": "[5 ] study did not make a significant difference in the time period of the current study .Some PTX procedures may have been missed if they were not coded .", "label": "", "metadata": {}, "score": "62.065453"}
{"text": "Gastrointestinal Effects .Severe HC , particularly encountered in the most advanced stages of neoplasias , can be complicated by a relevant pancreatic damage [ 49 ] .", "label": "", "metadata": {}, "score": "62.07445"}
{"text": "2310 - 2314 , 1997 .View at Google Scholar \u00b7 View at Scopus . A. Akcay , M. Kanbay , B. Huddam et al . , \" Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "62.122726"}
{"text": "Effects of thecalcimimetic cardiovascular disease , fracture , and health - related quality of life in secondary hyperparathyroidism .Kidney Int 2005 ; 68 : 1793 - 1800 18 .", "label": "", "metadata": {}, "score": "62.126038"}
{"text": "[ Google Scholar ] [ CrossRef ] .Teng , M. ; Wolf , M. ; Ofsthun , M.N. ; Lazarus , J.M. ; Hern\u00e1n , M.A. ; Camargo , C.A. , Jr. ; Thadhani , R. Activated injectable vitamin D and hemodialysis survival : A historical cohort study .", "label": "", "metadata": {}, "score": "62.168278"}
{"text": "436 - 442 , 1998 .View at Google Scholar \u00b7 View at Scopus .N. Mohsin , A. Jha , Y. Al Maimani , R. Malvathu , and S. Kallankara , \" Hypomagnesemia as a cause of severe cardiac arrythmias in the immediate postoperative period : a renal transplant case report , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "62.19838"}
{"text": "PubMed View Article .Malberti F , Marcelli D , Conte F , Limido A , Spotti D , Locatelli F : Parathyroidectomy in patients on renal replacement therapy : an epidemiologic study .", "label": "", "metadata": {}, "score": "62.256268"}
{"text": "PubMed View Article .Malberti F , Marcelli D , Conte F , Limido A , Spotti D , Locatelli F : Parathyroidectomy in patients on renal replacement therapy : an epidemiologic study .", "label": "", "metadata": {}, "score": "62.256268"}
{"text": "Placebo Comparator : Control .randomized , placebo - controlled trial comparing the effect of cinacalcet to placebo in controlling serum phosphorus .Drug : Placebo . cinacalcet , 30 mg daily , titrated to achieve serum phosphorus of 2.5 mg / dl , versus placebo , similarly titrated .", "label": "", "metadata": {}, "score": "62.317295"}
{"text": "Table 1 : Prevalence of Hypercalcemia ( HC ) after Kidney Transplantation ( KTx ) in different studies .First , it is worth noting that the older the study was the higher the prevalence of HC was evident , probably due to a less efficient control of SHP in earlier studies .", "label": "", "metadata": {}, "score": "62.38124"}
{"text": "At baseline , there was no significant difference in any biochemical target .None of the subjects in either group received native vitamin D or parathyroidectomy during the study period .", "label": "", "metadata": {}, "score": "62.42054"}
{"text": "This type of kidney damage can be defined as unspecific morphologic and/or functional cell changes which occur in the presence of HC and can regress or reduce after calcium level correction .", "label": "", "metadata": {}, "score": "62.487785"}
{"text": "Though not proven , there are experimental and clinical suggestions that HC can adversely affect either the graft ( nephrocalcinosis ) and other organs or systems ( vascular calcifications , erythrocytosis , pancreatitis , etc . ) .", "label": "", "metadata": {}, "score": "62.50461"}
{"text": "2158 - 2164 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Mazzaferro , M. Pasquali , F. Taggi et al . , \" Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation , \" Clinical Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "62.711708"}
{"text": "Over - range of FGF23 which could be not detected after dilution , were excluded in the analysis : 2 patients in the cinacalcet group at baseline ; 1 in the control group at baseline ; 1 in the control group at efficacy assessment phase .", "label": "", "metadata": {}, "score": "62.71371"}
{"text": "21 , pp .4296 - 4303 , 2010 .View at Google Scholar .O. Wrong , \" Nephrocalcinosis , \" in Oxford Textbook of Clinical Nephrology , A. M. Davidsen , J. S. Cameron , and J. P. Grunfeld , Eds . , pp .", "label": "", "metadata": {}, "score": "62.870457"}
{"text": "413 - 417 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. A. Borchhardt , H. Heinzl , E. Mayerw\u00f6ger , W. H. H\u00f6rl , M. Haas , and G. Sunder - Plassmann , \" Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "63.027443"}
{"text": "PubMed View Article .Am J Kidney Dis 2008 , 52 ( 3):519 - 530 .PubMed View Article .Goodman WG , Goldin J , Kuizon BD , Gales B , Sider D , Wang Y , Chung J , Emerick A , Greaser L , Elashoff RM , Salusky IB : Coronary - artery calcification in young adults with end - stage renal disease who are undergoing dialysis .", "label": "", "metadata": {}, "score": "63.100147"}
{"text": "685 - 690 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Messa , B. Brezzi , D. Cresseri , et al . , \" Hypercalcemia is associated with aortic calcification progression after renal transplantation , \" NDT Plus , vol . 1 , p. ii196 , 2008 .", "label": "", "metadata": {}, "score": "63.108242"}
{"text": "PubMed View Article .Clin J Am Soc Nephrol 2008 , 3 : 36 - 45 .PubMed View Article .Sprague SM , Evenepoel P , Curzi MP , Gonzalez MT , Husserl FE , Kopyt N , Sterling LR , Mix C , Wong G : Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCl .", "label": "", "metadata": {}, "score": "63.165977"}
{"text": "1029 - 1031 , 1993 .View at Google Scholar \u00b7 View at Scopus .G. M. Danovitch , N. J. Jamgotchian , P. H. Eggena et al . , \" Angiotensin - converting enzyme inhibition in the treatment of renal transplant erythrocytosis .", "label": "", "metadata": {}, "score": "63.18163"}
{"text": "Conclusions .A reduction in rates of parathyroidectomy was found after January 2006 , corresponding to cinacalcet availability .However , decreased rates may be due to other factors occurring simultaneously with cinacalcet introduction and further studies are needed to confirm these findings .", "label": "", "metadata": {}, "score": "63.184265"}
{"text": "It is also well acknowledged that the most severe degree of SHP is almost invariably associated with the nodular form of parathyroid gland hyperplasia which is much less prone to undergo spontaneous regression even after the uraemic state has been corrected [ 11 , 14 ] .", "label": "", "metadata": {}, "score": "63.25138"}
{"text": "In all cases , parathyroid carcinoma was diagnosed after PTx on the basis of local invasion ( No\u00bc5 ) , tumour pathology ( No\u00bc4 ) or distant metas- tases ( No\u00bc2 ) .", "label": "", "metadata": {}, "score": "63.255077"}
{"text": "Despite the fact that the drop in PTX rates is visually convincing during the intervention period , we tested six different intervention dates and statistically significant results may be due to chance by multiple testing ( limited power precluded applying correction factors such as Bonferroni ) .", "label": "", "metadata": {}, "score": "63.35239"}
{"text": "Clin J Am Soc Nephrol 2011 , 6 ( 4 ) : 913 - 921 .PubMed View Article .Goodman WG , Goldin J , Kuizon BD , Yoon C , Gales B , Sider D , Wang Y , Chung J , Emerick A , Greaser L , Elashoff RM , Salusky IB : Coronary - artery calcification in young adults with end - stage renal disease who are undergoing dialysis .", "label": "", "metadata": {}, "score": "63.426853"}
{"text": "Over the last decade , hypercalcemia ( HC ) has received much attention from the renal transplant community since it has been claimed to have a negative impact on both the graft and patient outcomes .", "label": "", "metadata": {}, "score": "63.431473"}
{"text": "J Am Stat Assoc 1975 , 70 ( 349 ) : 70 - 79 .View Article .U.S. Renal Data System : USRDS 2011Annual Data Report : Atlas of Chronic Kidney Disease and End - Stage Renal Disease in the United States .", "label": "", "metadata": {}, "score": "63.437923"}
{"text": "In the first operation , 2/3 of one kidney was surgically removed .After a one - week recovery , the other kidney was removed , leaving the rat with 1/6 of its original renal capacity .", "label": "", "metadata": {}, "score": "63.4402"}
{"text": "Parathyromatosis and the challenge of treatment .Am J Kidney Dis 2006 ; 48 : 502 - 505 22 .Colloton M , Shatzen E , Miller G et al .", "label": "", "metadata": {}, "score": "63.493965"}
{"text": "289 , no . 8 , pp .398 - 401 , 1973 .View at Google Scholar \u00b7 View at Scopus .T. Cundy , J. A. Kanis , G. Heynen , P. J. Morris , and D. O. Oliver , \" Calcium metabolism and hyperparathyroidism after renal transplantation , \" Quarterly Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "63.628334"}
{"text": "The best way for avoiding HC after KTx is to optimally treat SHP before KTx .However , two main questions still remain unsolved .The first question concerns the criteria for choosing the patient on the transplant waiting - list who should be referred to PTX or maintained on medical therapy .", "label": "", "metadata": {}, "score": "63.650013"}
{"text": "12 , p. 1352 , 1976 .View at Google Scholar \u00b7 View at Scopus .T. W. Frick , D. S. Fryd , D. E. R. Sutherland , R. L. Goodale , R. L. Simmons , and J. S. Najarian , \" Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients .", "label": "", "metadata": {}, "score": "63.72464"}
{"text": "[ Google Scholar ] [ CrossRef ] .J. Ren .Nutr .[ Google Scholar ] [ CrossRef ] .Block , G.A. ; Klassen , P.S. ; Lazarus , J.M. ; Ofsthun , N. ; Lowrie , E.G. ; Chertow , G.M. Mineral metabolism , mortality , and morbidity in maintenance hemodialysis .", "label": "", "metadata": {}, "score": "63.75308"}
{"text": "In a large cohort with a 5-year follow - up and in a multicenter network setting , islet transplantation was safe and efficient in restoring good and lasting glycemic control , and to prevent severe hypoglycemia in patients with type 1 diabetes .", "label": "", "metadata": {}, "score": "63.783157"}
{"text": "In response to reduced serum calcium , a \" rebound \" in PTH can occur as the body perceives a state of hypocalcemia .This is seen in Table 1 and Figure 3 B , where the cinacalcet - treated animals show an increased PTH level over baseline at the 16 hour time point .", "label": "", "metadata": {}, "score": "64.04509"}
{"text": "Relapses of secondary hyperparathyroidism ( SHPTH ) after parathyroidectomy ( PTx ) in haemodialysis patients are relatively frequent .Calcimimetics ( cinacalcet HCl ) offer a new therapeutic opportunity for their treatment .", "label": "", "metadata": {}, "score": "64.05165"}
{"text": "154 , no .5 , pp .487 - 489 , 1987 .View at Google Scholar \u00b7 View at Scopus .P. Evenepoel , K. Claes , D. Kuypers , B. Maes , and Y. Vanrenterghem , \" Impact of parathyroidectomy on renal graft function , blood pressure and serum lipids in kidney transplant recipients : a single centre study , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "64.086716"}
{"text": "Whether different immune - suppressive drugs might be in some way related to HC is not completely clear .Steroids have been recognized to carry with them a number of effects potentially affecting calcium metabolism ( antivitamin D effect , calciuretic activity , induction of osteoblast apoptosis , etc . ) .", "label": "", "metadata": {}, "score": "64.1262"}
{"text": "These areas of uncertainty should be clarified by a randomized controlled trial before a widespread use of the drug can be suggested in KTx patients .", "label": "", "metadata": {}, "score": "64.188095"}
{"text": "97 - 104 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. S. David , S. Sakai , B. L. Brennan et al . , \" Hypercalcemia after renal transplantation .", "label": "", "metadata": {}, "score": "64.19525"}
{"text": "Taken together all these data strongly suggest that the occurrence of HC after KTx is mostly sustained by the persistence of a severe form of PT - HPT which is mainly secondary to the previous state of mineral metabolism derangement developed throughout the often long story of chronic kidney disease .", "label": "", "metadata": {}, "score": "64.32569"}
{"text": "Furthermore , post hoc analysis of these studies reported that cinacalcet modulated FGF23 reduction .However , the specific mechanism of cinacalcet effect on FGF23 suppression has not been elucidated .", "label": "", "metadata": {}, "score": "64.37983"}
{"text": "J Pharm Exp Ther 2013 , 346 ( 2):229 - 240 .View Article .Martin KJ , Pickthorn K , Huang S , Block GA , Vick A , Mount PF , Power DA , Bell G : AMG 416 ( velcalcetide ) is a novel peptide for the treatment of secondary hyperparathyroidism in a single - dose study in hemodialysis patients .", "label": "", "metadata": {}, "score": "64.45798"}
{"text": "Study sample .Chronic dialysis was defined as at least 90 days of dialysis , and therefore patients with less than 90 days of follow - up were excluded .", "label": "", "metadata": {}, "score": "64.47804"}
{"text": "The demographic variables , percent change in Ca , P , log - transformed iPTH , and the vitamin D dose were used for univariate analysis .", "label": "", "metadata": {}, "score": "64.52673"}
{"text": "For general information , see Learn About Clinical Studies .Please refer to this study by its ClinicalTrials.gov identifier : NCT01011114 Clinical Impact of Hypercalcemia in Kidney Transplant .", "label": "", "metadata": {}, "score": "64.65541"}
{"text": "PubMed View Article .K / DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 2003 , 42 ( 4 Suppl 3 ) : S1-S201 .", "label": "", "metadata": {}, "score": "64.74634"}
{"text": "At the end of study , decrease in calcitriol usage and mean weekly dosage of intravenous calcitriol was observed in the VitD group .Discussion .", "label": "", "metadata": {}, "score": "64.76264"}
{"text": "A recent paper reported that KTx patients on rapamycin therapy would be more prone to develop persistent SHP , frequently associated with HC [ 26 ] .", "label": "", "metadata": {}, "score": "64.778885"}
{"text": "One of the possible explanations is genetic variation of CaSR , such as polymorphism , for the diverse response of cinacalcet .[28 ] .", "label": "", "metadata": {}, "score": "64.93164"}
{"text": "In the saline - treated group , plasma PTH levels fluctuated over the 4-week study but generally remained at or above the 400 - 500 pg / mL starting level ( Figure 3 A ) .", "label": "", "metadata": {}, "score": "64.973366"}
{"text": "In the present study , risk factors for PTX were female gender , age 40 - 55 years , and non - diabetic cause of renal disease .", "label": "", "metadata": {}, "score": "64.99859"}
{"text": "1934 - 1941 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . F. N. \u00d6zdemir , B. Afsar , A. Akgul , C. Usluo\u01e7ullari , A. Ak\u00e7ay , and M. Haberal , \" Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients , \" Transplantation Proceedings , vol .", "label": "", "metadata": {}, "score": "65.145966"}
{"text": "PubMed View Article .Foley RN , Li S , Liu J , Gilbertson DT , Chen SC , Collins AJ : The fall and rise of parathyroidectomy in U.S. hemodialysis patients , 1992 to 2002 .", "label": "", "metadata": {}, "score": "65.17281"}
{"text": "PubMed View Article .Foley RN , Li S , Liu J , Gilbertson DT , Chen SC , Collins AJ : The fall and rise of parathyroidectomy in U.S. hemodialysis patients , 1992 to 2002 .", "label": "", "metadata": {}, "score": "65.17281"}
{"text": "RAMQ codes for PTX did not change during the study period .If any percutaneous ethanol ablation procedures of the parathyroid were carried out , these would not be captured , as there is no specific code for this new technique .", "label": "", "metadata": {}, "score": "65.17358"}
{"text": "Abstract .Hypercalcemia ( HC ) has been variably reported in kidney transplanted ( KTx ) recipients ( 5 - 15 % ) .Calcium levels peak around the 3rd month after KTx and thereafter slightly reduce and stabilize .", "label": "", "metadata": {}, "score": "65.34212"}
{"text": "Ca - free phosphate binders were prescribed for 37.5 % and 42.4 % , respectively .Mean vitamin D dose at each time point .Error bars denote standard deviation ( SD ) .", "label": "", "metadata": {}, "score": "65.45529"}
{"text": "However , this study was limited to 2007 ( less than three years after cinacalcet marketing ) [ 5 ] .In addition , the effect of formulary listing of cinacalcet for reimbursement on PTX rates has not been studied .", "label": "", "metadata": {}, "score": "65.50682"}
{"text": "2362 - 2365 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. W. Peng , J. L. Logan , S. H. James , K. M. Scott , and Y. H. Lien , \" Cinacalcet - associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient , \" American Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "65.51265"}
{"text": "60 , no . 2 , pp .132 - 137 , 1995 .View at Google Scholar \u00b7 View at Scopus .M. Mrug , T. Stopka , B. A. Julian , J. F. Prchal , and J. T. Prchal , \" Angiotensin II stimulates proliferation of normal early erythroid progenitors , \" Journal of Clinical Investigation , vol .", "label": "", "metadata": {}, "score": "65.73826"}
{"text": "A total of 81 dialysis patients were enrolled ( 40 subjects in d -Cinacalcet group and 41 subjects in VitD group ) .Demographic data including age , gender , duration on dialysis and biochemical data were reviewed and recorded .", "label": "", "metadata": {}, "score": "65.74514"}
{"text": "Unlike the EVOLVE trial , there was no possibility of cross - over of medication between the two arms , since cinacalcet was not commercially available in Korea during the study period [ 23 ] .", "label": "", "metadata": {}, "score": "65.84061"}
{"text": "Nephrol .Dial .Transplant .[ Google Scholar ] .Rothe , H.M. ; Shapiro , W.B. ; Sun , W.Y. ; Chou , S.Y. Calcium - Sensing receptor gene polymorphism Arg990Gly and its possible effect on response to cinacalcet HCl .", "label": "", "metadata": {}, "score": "65.909294"}
{"text": "PubMed View Article .Padhi D , Harris RZ , Salfi M , Noveck RJ , Sullivan JT : Pharmacokinetics and pharmacodynamics of cinacalcet in hepatic impairment : phase I , open - label , parallel - group , single - dose , single - centre study .", "label": "", "metadata": {}, "score": "65.921906"}
{"text": "A positive and significant correlation was found between nodular volume with ethanol injected and time from parathyroidectomy .Only one patient required hospitalization due to severe hypocalcaemia .", "label": "", "metadata": {}, "score": "65.92871"}
{"text": "461.7 to 573.7 ? 128.7pg / ml , P\u00bc0.01 , parathyroid cells notoriously , arenot 4 of 7C. Page 5 .Table 3 .Rx 2 .", "label": "", "metadata": {}, "score": "66.033554"}
{"text": "Nishi H , Nii - Kono T , Nakanishi S , Yamazaki Y , Yamashita T , Fukumoto S , Ikeda K , Fujimori A , Fukagawa M : Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism .", "label": "", "metadata": {}, "score": "66.16093"}
{"text": "Cinacalcet group exhibited more drop - outs that the control group .The analysis of FGF23 change was performed on a per - protocol basis .", "label": "", "metadata": {}, "score": "66.25932"}
{"text": "Patients without APA or AVK have less comorbidities , less bleeding and thrombotic events , and better survival .Analytic description of our data is expected to get a risk / benefit ratio of APA and AVK treatment in their different uses .", "label": "", "metadata": {}, "score": "66.2917"}
{"text": "Eur Heart J 2011 , 32 : 2688 - 2696 .PubMed View Article .Mirza MA , Larsson A , Melhus H , Lind L , Larsson TE : Serum intact FGF23 associate with left ventricular mass , hypertrophy and geometry in an elderly population .", "label": "", "metadata": {}, "score": "66.29231"}
{"text": "PubMed View Article .National Kidney foundation : K / DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease .Am J Kidney Dis 2003 , 42 ( 3):S1 - 201 .", "label": "", "metadata": {}, "score": "66.31435"}
{"text": "AMG 416 is a novel peptide agonist of the CaSR that is being developed as an intravenous ( IV ) product for the treatment of CKD with SHPT .", "label": "", "metadata": {}, "score": "66.334045"}
{"text": "Table 3 .Risk factors for parathyroidectomy , as incidence rate ratios ( IRR ) , in the Swedish dialysis- and transplant population .There were few events and person - years in the first two years the SNR was operating , 1991 and 1992 , hence incidence rate ratios for those years had wide confidence intervals .", "label": "", "metadata": {}, "score": "66.367584"}
{"text": "Methods .Study population .Seven university - affiliated hospitals in Korea participated in the CUPID trial .After a 4-week washout period during which vitamin D was withheld , iPTH and calcium levels were measured again .", "label": "", "metadata": {}, "score": "66.41133"}
{"text": "Scandinavian Quality Register for Thyroid Parathyroid and Adrenal Surgery .References .Kestenbaum B , Seliger SL , Gillen DL , Wasse H , Young B , Sherrard DJ , Weiss NS , Stehman - Breen CO : Parathyroidectomy rates among United States dialysis patients : 1990 - 1999 .", "label": "", "metadata": {}, "score": "66.46106"}
{"text": "These longer - term effects may in part arise from reversal of abnormal parathyroid gland physiology , as observed in other studies with AMG 416 [ 5 ] .", "label": "", "metadata": {}, "score": "66.492325"}
{"text": "Statistical analysis .Means and standard deviations were used for continuous variables , and column percent for categorical variables .Time at risk in person - years was calculated for different categories of age , geographical region of treatment , cause of renal disease , and time with functioning graft , stratified by gender .", "label": "", "metadata": {}, "score": "66.57247"}
{"text": "PubMed View Article .The EVOLVE Trial Investigators : Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis .N Engl J Med 2012 , 367 : 2482 - 2494 .", "label": "", "metadata": {}, "score": "66.586815"}
{"text": "11 , pp .2546 - 2552 , 2007 .View at Google Scholar . A. Torres , V. Lorenzo , and E. Salido , \" Calcium metabolism and skeletal problems after transplantation , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "66.594666"}
{"text": "Serum samples were analyzed for total calcium content at SRI ( Menlo Park , CA ) using the Roche Cobas C-501 autoanalyzer .Results .AMG 416 suppresses PTH in animals with severely compromised renal function .", "label": "", "metadata": {}, "score": "66.605804"}
{"text": "PubMed View Article .Padhi D , Harris R : Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride .Clin Pharmacokinet 2009 , 48 ( 5):303 - 311 .", "label": "", "metadata": {}, "score": "66.64424"}
{"text": "However , there was no symptomatic , or fatal hypocalcemia in both groups .All safety analyses were performed by intention - to - treat method .", "label": "", "metadata": {}, "score": "66.647484"}
{"text": "View at Google Scholar \u00b7 View at Scopus .W. Reinhardt , H. Bartelworth , F. Jockenh\u00f6vel et al . , \" Sequential changes of biochemical bone parameters after kidney transplantation , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "66.69119"}
{"text": "On the other hand , a number of small studies have been published in recent years on the use of cinacalcet in KTx recipients which can give some indicative instruction on this topic [ 8 , 58 - 68 ] .", "label": "", "metadata": {}, "score": "66.782845"}
{"text": "Li S , Chen YW , Peng Y , Foley RN , St Peter WL : Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007 .", "label": "", "metadata": {}, "score": "66.888016"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Ghanekar , B. J. Welch , O. W. Moe , and K. Sakhaee , \" Post - renal transplantation hypophosphatemia : a review and novel insights , \" Current Opinion in Nephrology and Hypertension , vol .", "label": "", "metadata": {}, "score": "66.98729"}
{"text": "Conflicting with this trend , other nephrologists advocate some grounds for limiting the indication to PTX before KTx to only the most severe forms of SHP .", "label": "", "metadata": {}, "score": "67.018394"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. El - Amm , M. D. Doshi , A. Singh et al . , \" Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation , \" Transplantation , vol .", "label": "", "metadata": {}, "score": "67.04601"}
{"text": "Abbreviations : PTX , parathyroidectomy ; py , person - year .Trends in medication use are given in Figure 4 and average daily doses are shown in Table 2 .", "label": "", "metadata": {}, "score": "67.05777"}
{"text": "5 , pp .1193 - 1200 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Stavroulopoulos , M. J. Cassidy , C. J. Porter , D. J. Hosking , and S. D. Roe , \" Vitamin D status in renal transplant recipients , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "67.120125"}
{"text": "1714 - 1720 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Evenepoel , K. Claes , D. R. Kuypers , F. Debruyne , and Y. Vanrenterghem , \" Parathyroidectomy after successful kidney transplantation : a single centre study , \" Nephrology Dialysis Transplantation , vol .", "label": "", "metadata": {}, "score": "67.13154"}
{"text": "1048 - 1053 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . U.Christians , K. Kohlhaw , J. Budniak et al . , \" Ciclosporin metabolite pattern in blood and urine of liver graft recipients .", "label": "", "metadata": {}, "score": "67.16929"}
{"text": "We use to treat all PTx patients , who represent a very selected category , with a Ca concentration in the dialysate of 6.0mg / dl at variance with Ca concentra- tion of 5.0mg / dl recommended by the NKF / K - DOQI guidelines [ 9].", "label": "", "metadata": {}, "score": "67.213776"}
{"text": "This new class of agents augments the sensitivity of CaSR of parathyroid glands to extra- cellular calcium ( Ca ) concentrations , by that way causing both the suppression of parathyroid hormone ( PTH ) secretion [ 5 ] and of cellular proliferation [ 6].", "label": "", "metadata": {}, "score": "67.2216"}
{"text": "Because it produced the most efficient number of points for this analysis , bimonthly PTX incidence rates were calculated throughout the study duration .The adequate candidate model was chosen according to published guidelines ( parameters significance , graphical evaluation of residuals , and Akaike Information Criterion ) [ 13 , 14 ] .", "label": "", "metadata": {}, "score": "67.27306"}
{"text": "A limitation of the present study is the lack of biochemical data , such as levels of parathyroid hormone , and of information on medical treatment .", "label": "", "metadata": {}, "score": "67.28584"}
{"text": "Nephrol Dial Transplant 2006 ; 21 : 968 - 974 15 .Schantz A , Castleman B. Parathyroid carcinoma : A study of 70 cases .", "label": "", "metadata": {}, "score": "67.319534"}
{"text": "Histological studies of the parathyroid glands with light microscopy were performed on seven serial sections of the glands .Diffuse hyperplasia was defined as increased numbers of parenchymal cells with normal lobular struc- tures , and nodular hyperplasia as at least one well circumscribed , encapsulated and virtually fat cell - free accu- mulation of parenchymal cells [ 14].", "label": "", "metadata": {}, "score": "67.357994"}
{"text": "PubMed View Article .Drueke TB : The pathogenesis of parathyroid gland hyperplasia in chronic renal failure .Kidney Int 1995 , 48 ( 1):259 - 272 .", "label": "", "metadata": {}, "score": "67.42821"}
{"text": "24 , pp .2326 - 2333 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. S. Pinheiro , N. O. C\u00e2mara , K. S. Osaki , L. A. Ribeiro De Moura , and A. Pacheco - Silva , \" Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long - term graft survival , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "67.4329"}
{"text": "Our aim was to evaluate islet transplantation results at 1 year according to the presence of IA .Methods : Our work is a retrospective , case - control study , comparing IA - negative and IA - positive patients among the cohort of patients with type 1 diabetes transplanted within the Swiss - French GRAGIL network between 2003 and 2010 .", "label": "", "metadata": {}, "score": "67.4834"}
{"text": "Few studies have evaluated trends in PTX rates , and only one has reported rates after the release of the KDOQI clinical practice guidelines in 2003 , and none have included patients well beyond introduction of calcimetics [ 5 - 8 ] .", "label": "", "metadata": {}, "score": "67.49845"}
{"text": "Rodriguez M , Canalejo A , Garfia B , Aguilera E , Almaden Y. Pathogenesis of refractory secondary hyperparathyroidism .Kidney Int 2002 ; 61 [ Suppl 80 ] : S155-S160 3 .", "label": "", "metadata": {}, "score": "67.50792"}
{"text": "However , cinacalcet was not reimbursed via the provincial formulary until June 2006 , and was only reimbursed by private insurance companies for a few patients who had private insurances coverage ( less than 22 % annually ) .", "label": "", "metadata": {}, "score": "67.61831"}
{"text": "PubMed View Article .Donate - Correa J , Muros - de - Fuentes M , Mora - Fernandez C , Navarro - Gonzalez JF : FGF23/Klotho axis : phosphorus , mineral metabolism and beyond .", "label": "", "metadata": {}, "score": "67.62067"}
{"text": "In contrast , for AMG 416-treated animals , PTH levels remained suppressed at the 16 hr time point and were still 40 - 50 % reduced from baseline values at 48 hr following dosing ( on Day 28 ) .", "label": "", "metadata": {}, "score": "67.717575"}
{"text": "However , there are some plausible reasons for believing that sustained high calcium levels might have some potential negative effect at least on the vascular calcification ( VC ) process .", "label": "", "metadata": {}, "score": "67.74281"}
{"text": "42 - 50 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. T. Nguyen , E. Coche , E. Goffin et al . , \" Prevalence and determinants of coronary and aortic calcifications assessed by chest CT in renal transplant recipients , \" American Journal of Nephrology , vol .", "label": "", "metadata": {}, "score": "67.88195"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Courbebaisse , E. Thervet , J. C. Souberbielle et al . , \" Effects of vitamin D supplementation on the calcium - phosphate balance in renal transplant patients , \" Kidney International , vol .", "label": "", "metadata": {}, "score": "67.91307"}
{"text": "Almost half of all patients ( 49 % ) died during follow - up and 15 % were transplanted .As shown in Table 1 , patient age increased with time , while proportions of incident patients and of patients on peritoneal dialysis decreased with time .", "label": "", "metadata": {}, "score": "67.932236"}
{"text": "PubMed View Article .Li S , Chen YW , Peng Y , Foley RN , St Peter WL : Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007 .", "label": "", "metadata": {}, "score": "68.036316"}
{"text": "On the other hand , frequent use of aluminum hydroxide is noted in our study , which is because of the severity of UHPT in our subjects and they were prone to suffer hypercalcemia under administration of calcium - based phosphate binders .", "label": "", "metadata": {}, "score": "68.10972"}
{"text": "Main outcome measures .Results .After adjustment , cinacalcet treatment was independently associated with the serum FGF23 reduction .Conclusion .Cinacalcet treatment was independently associated with the reduction of FGF23 in our PD patients .", "label": "", "metadata": {}, "score": "68.22376"}
{"text": "The most common adverse reactions were digestive symptoms .In the cinacalcet group , nausea / vomiting ( 18.2 % ) , dyspepsia ( 3.0 % ) , diarrhea ( 3.0 % ) , and constipation ( 3.0 % ) were present .", "label": "", "metadata": {}, "score": "68.366135"}
{"text": "10 , pp .2391 - 2395 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .O. I. Egbuna , J. G. Taylor , D. A. Bushinsky , and M. S. Zand , \" Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure , \" Clinical Transplantation , vol .", "label": "", "metadata": {}, "score": "68.37978"}
{"text": "Table 1 .Baseline characteristics in the Swedish dialysis- and transplant population .After adjustment , female gender , age group 40 - 55 years as compared with other age groups , and non - diabetic cause of end - stage renal disease were all associated with an increased risk for PTX , Table 3 .", "label": "", "metadata": {}, "score": "68.38222"}
{"text": "Our aim was to investigate the incidence , regional distribution and factors associated with PTX as well as possible temporal changes , in the Swedish dialysis and transplant population .", "label": "", "metadata": {}, "score": "68.42896"}
{"text": "The six patients undergoingthe showed at 6 months a not significant decrease in the are relativelyfrequent .patients of our conventionaltreatment mean serum levels of iPTH and a not significant increase in the mean serum levels of Ca , P and Ca?P product , when compared with the baseline values .", "label": "", "metadata": {}, "score": "68.440315"}
{"text": "CUPID included a 4-week screening for vitamin D washout , a 12-week dose - titration , and a 4-week assessment phases .", "label": "", "metadata": {}, "score": "68.558395"}
{"text": "6 , pp .1055 - 1062 , 1991 .View at Google Scholar \u00b7 View at Scopus .K. Borchhardt , I. Sulzbacher , T. Benesch , M. F\u00f6dinger , G. Sunder - Plassmann , and M. Haas , \" Low - turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "68.59796"}
{"text": "On the other hand , recent data lessened this conviction , showing that no difference in the long - term graft outcome was evident between KTx patients who were submitted to PTX as compared with a comparable group of patients who were not [ 53 ] .", "label": "", "metadata": {}, "score": "68.61105"}
{"text": "The best way to reduce the occurrence of HC after KTx is to treat as best we can the secondary hyperparathyroidism ( SHP ) during the uraemic stages .", "label": "", "metadata": {}, "score": "68.727295"}
{"text": "The longitudinal changes of parameters of CKD - mineral bone disease at baseline , 3 months , and 6 months after initiating treatment of moderate to severe UHPT is displayed in Table 2 .", "label": "", "metadata": {}, "score": "68.81431"}
{"text": "In this large population - based study , a significant drop in PTX rates among patients receiving dialysis after January 1 , 2006 is shown .", "label": "", "metadata": {}, "score": "69.00386"}
{"text": "There is some evidence that HC may have a negative clinical impact on either the graft and/or the patient outcome .Though it is not always easy to dissect the two clinical fields from each other , we will deal with each one separately so as to treat more clearly the topic .", "label": "", "metadata": {}, "score": "69.02692"}
{"text": "PubMed View Article .N Engl J Med 2012 , 367 : 2482 - 2494 .PubMed View Article .Ferrari SL , Bonjour JP , Rizzoli R : Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men .", "label": "", "metadata": {}, "score": "69.045425"}
{"text": "Serum alkaline phosphatase also declined ( 561.8 + /- 169.6 U / L pretreatment to 390.3 + /- 110.3 U / L posttreatment pg / ml ) .", "label": "", "metadata": {}, "score": "69.083725"}
{"text": "Study design and treatments .This is a multicenter , open - labeled , and randomized controlled study fulfilled at seven sites .The 20-week study consisted of three phases : a 4-week screening and vitamin D washout phase , a 12-week dose - titration phase , and a 4-week efficacy - assessment phase .", "label": "", "metadata": {}, "score": "69.09044"}
{"text": "Furthermore , the baseline levels for iPTH , Ca , P , and Ca X P after vitamin D washout , and the FGF23 were similar between both groups .", "label": "", "metadata": {}, "score": "69.15831"}
{"text": "Kazama JJ , Sato F , Omori K et al .Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients .Kidney Int 2005 ; 67 : 1120 - 1125 17 .", "label": "", "metadata": {}, "score": "69.20886"}
{"text": "Thymic output significantly decreased one - year posttransplant in ATG - treated patients .ATG was associated with a significant decrease in l - HPC / m - HPC ratio .", "label": "", "metadata": {}, "score": "69.470634"}
{"text": "Mortality rate was highly dependent on treatment and age ; transplanted patients aged 60 - 69 had a 27/1000 patients - year mortality rate versus 133 for a dialysis patient .", "label": "", "metadata": {}, "score": "69.48228"}
{"text": "Secondary hyperparathyroidism ( SHPT ) , common in ESRD , persists following renal transplantation resulting in profound hypophosphatemia .This can lead to hemolysis , congestive heart failure , rhabdomyolysis .", "label": "", "metadata": {}, "score": "69.51463"}
{"text": "323 - 329 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .W. Gwinner , S. Suppa , M. Mengel et al . , \" Early calcification of renal allografts detected by protocol biopsies : causes and clinical implications , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "69.638824"}
{"text": "551 - 558 , 2002 .View at Google Scholar \u00b7 View at Scopus .K. Schankel , J. Robinson , R. D. Bloom et al . , \" Determinants of coronary artery calcification progression in renal transplant recipients , \" American Journal of Transplantation , vol .", "label": "", "metadata": {}, "score": "69.66157"}
{"text": "Evaluation of AMG 416 in 5/6 Nephrectomized Rats .A 4-week , repeat dose study was performed in 5/6 nephrectomized male SD rats at CRL ( Wilmington , MA ) .", "label": "", "metadata": {}, "score": "69.68797"}
{"text": "Patients were censored at PTX , death , kidney transplantation , emigration out of the province , or end of the study ( December 31 , 2010 ) .", "label": "", "metadata": {}, "score": "69.866295"}
{"text": "Some of our preliminary results , produced as yet only in abstract form [ 23 ] , suggested that aortic calcifications , evaluated according to Kauppila et al .", "label": "", "metadata": {}, "score": "69.89648"}
{"text": "One - year posttransplant T cell RTL and RTA were consequently lower in ATG - treated patients .ATG is associated with accelerated immune senescence .", "label": "", "metadata": {}, "score": "69.91809"}
{"text": "Both studies included a control ( vehicle ) group and a comparison cinacalcet group ( po dosing at 30 mg / kg and 10 mg / kg for the 1K1C and 5/6 Nx studies , respectively ) .", "label": "", "metadata": {}, "score": "70.160706"}
{"text": "The regional distribution of PTX was heterogeneous with the lowest rate in the Northern region .We believe , as was also suggested by previous authors , that lower access to specialist nephrology might account for these regional differences [ 2 ] .", "label": "", "metadata": {}, "score": "70.234085"}
{"text": "Analysis of longitudinal within - group continuous data was assessed by paired tests .Ethical Issues .The study was approved by the Institutional Review Board of Chang - Gung Memorial Hospital ( IRB number : 101 - 4851B ) .", "label": "", "metadata": {}, "score": "70.24003"}
{"text": "Alfacalcidol and calcitriol are by far the two frequently used activated vitamin D products in Qu\u00e9bec .For all analyses , a p - value of less than 0.05 was considered statistically significant .", "label": "", "metadata": {}, "score": "70.29007"}
{"text": "PubMed View Article .Antoniucci DM , Yamashita T , Portale AA : Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men .J Clin Endocrine Metab 2006 , 91 : 3144 - 3149 .", "label": "", "metadata": {}, "score": "70.39441"}
{"text": "In other words , rates did not appear to increase or decrease over time except at the intervention point .Results for the ARIMA and Poisson analyses were similar when time periods not covered by the drug plan were excluded , except that June 2005 became statistically significant in addition to January 2006 .", "label": "", "metadata": {}, "score": "70.42459"}
{"text": "PubMed View Article .Liu S , Tang W , Zhou J , Stubbs JR , Luo Q , Pi M , Quarles LD : Fibroblast growth factor 23 is a counter - regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 2006 , 17 : 1305 - 1315 .", "label": "", "metadata": {}, "score": "70.49605"}
{"text": "It is worth stressing that the results of all the quoted studies are flawed in many critical aspects , since most of them were performed in relatively small groups of patients , had a retrospective design , and a lack of a control group .", "label": "", "metadata": {}, "score": "70.51213"}
{"text": "Parathyroidectomy ( PTx ) is reserved for dialysis patients who have severe osteitis fibrosa , unresponsive to vitamin D therapy or in whom such a treatment is contraindicated .", "label": "", "metadata": {}, "score": "70.627914"}
{"text": "PubMed View Article .Clin J Am Soc Nephrol 2008 , 3 : 1718 - 1725 .PubMed View Article .Kirkpantur A , Balci M , Gurbuz OA , Afsar B , Canbakan B , Akdemir R , Ayli MD : Serum fibroblast growth factor-23 ( FGF-23 ) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients .", "label": "", "metadata": {}, "score": "70.67628"}
{"text": "According to Amgen data , cinacalet claims were estimated at 241 in 2005 and 385 in 2006 ( Amgen internal data ) .Assuming monthly claims ( 12 claims per patients per year ) , it can be estimated that 20 patients received cinacalcet through private insurance companies in 2005 and 32 patients in 2006 .", "label": "", "metadata": {}, "score": "70.70888"}
{"text": "Another factor which has been cited as a potential cause of HC after KTx is the supposed reabsorption of vascular calcifications ( VC ) [ 20 ] .", "label": "", "metadata": {}, "score": "70.91594"}
{"text": "Abbreviations .FGF23 : .Fibroblast growth factor 23 .CUPID : .Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect Of iPTH Level .", "label": "", "metadata": {}, "score": "71.00714"}
{"text": "After 2005 the PTX rate fell and remained lower throughout the study period .This decrease was associated in time with the introduction of paracalcitol in December 2004 and calcimimetics in 2005 in Sweden .", "label": "", "metadata": {}, "score": "71.094795"}
{"text": "Blood samples ( 0.45 mL ; tail vein ) were taken for PTH and calcium analysis prior to dosing and at 6 and 16 hrs post - dose on Days 7 , 14 , 21 and 28 .", "label": "", "metadata": {}, "score": "71.120605"}
{"text": "Very low and very high parathyroid hormone levels were associated with adverse outcomes .In the absence of definitive evidence in support of a specific parathyroid hormone target , there is an urgent need for additional research to inform clinical practice .", "label": "", "metadata": {}, "score": "71.41757"}
{"text": "A number of experimental studies have clearly demonstrated that HC can induce renal damage by different mechanisms .In animal models , three different types of Calcium - mediated kidney damage have been described .", "label": "", "metadata": {}, "score": "71.4863"}
{"text": "PTX rates did not differ by gender .However , trends of PTX rates were similar across strata .Parathyroidectomy rates by age , sex , and incidence / prevalence .", "label": "", "metadata": {}, "score": "71.48801"}
{"text": "View at Google Scholar .B. J. Nankivell , R. J. Borrows , C. L. S. Fung , P. J. O'Connell , R. D. M. Allen , and J. R. Chapman , \" The natural history of chronic allograft nephropathy , \" New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "71.53145"}
{"text": "A total of 12 795 chronic dialysis patients ( mean age 64 years , 39 % female , 82 % hemodialysis ) were followed for a mean follow - up of 3.3 years .", "label": "", "metadata": {}, "score": "71.56076"}
{"text": "Another explanation would be a change of indication or physician attitude toward PTX .For example , physicians may now tolerate higher PTH level thresholds before considering a PTX .", "label": "", "metadata": {}, "score": "71.60469"}
{"text": "3103 - 3105 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. D. Goldberg and E. M. Herschmann , \" Letter : hypercalcemia and pancreatitis , \" Journal of the American Medical Association , vol .", "label": "", "metadata": {}, "score": "71.85712"}
{"text": "Therefore , we could postulate that the dietary P intake was similar between the two groups , although the present study did not analyze dietary phosphorus intake .", "label": "", "metadata": {}, "score": "71.981094"}
{"text": "11 , pp .1301 - 1303 , 2008 .View at Google Scholar .G. Dayanithi , C. Viero , and I. Shibuya , \" The role of calcium in the action and release of vasopressin and oxytocin from CNS neurones / terminals to the heart , \" Journal of Physiology and Pharmacology , vol .", "label": "", "metadata": {}, "score": "72.158585"}
{"text": "They have more thrombotic and bleeding events than the general population .The balance of risks and benefits of drugs is not precisely defined .The aim of this study is to describe the practices patterns concerning oral anticoagulants ( AVK ) and antiplatelet agents ( APA ) , and to investigate their impact on the survival and the occurrence of thrombotic and bleeding events .", "label": "", "metadata": {}, "score": "72.264694"}
{"text": "The distribution of UHPT severity did not differ between the two groups .There were no significant differences in their baseline levels of iPTH , calcium , phosphorous , calcium phosphate product ( Ca \u00d7 P ) , alkaline phosphatase and hemoglobin .", "label": "", "metadata": {}, "score": "72.390686"}
{"text": "Ils pr\u00e9sentent davantage d'\u00e9v\u00e9nements thrombotiques et h\u00e9morragiques que la population g\u00e9n\u00e9rale , avec une balance b\u00e9n\u00e9fices / risques m\u00e9dicamenteuse moins connue .Le but de notre \u00e9tude est de d\u00e9crire les pratiques de prescription des antiagr\u00e9gants plaquettaires ( AAP ) et antivitamine K ( AVK ) , et d'\u00e9tudier l'impact de ces pratiques sur la survie et la survenue d'\u00e9v\u00e9nements thrombotiques et / ou h\u00e9morragiques .", "label": "", "metadata": {}, "score": "72.44598"}
{"text": "It is not surprising that only 61 % subjects in the VitD group received calcitriol treatment at the end of 6 months .The intermittent interruption and decreased dosage of calcitriol during the treatment period contributed to only modest reduction in iPTH levels with a lesser proportion able to achieve the K / DOQI - recommended biochemical targets in the VitD group .", "label": "", "metadata": {}, "score": "72.484055"}
{"text": "Am J Kidney Dis 2003 ; 42 [ Suppl 3 ] : S1-S201 10 .Quarles LD , Sherrard DJ , Adler S et al .", "label": "", "metadata": {}, "score": "72.49275"}
{"text": "We tested the hypothesis that ATG induces accelerated immune senescence in renal transplant recipients ( RTR ) .Immune senescence biomarkers were analyzed at transplant and one - year later in 97 incident RTR -62 patients receiving ATG and 35 receiving anti - CD25 mAb ( \u03b1 - CD25 ) .", "label": "", "metadata": {}, "score": "72.51266"}
{"text": "In addition , information on drugs dispensed to all individuals age 65 years and older , individuals on welfare and workers insured by the provincial drug plan is captured within the database .", "label": "", "metadata": {}, "score": "72.54664"}
{"text": "Parathyroidectomy rates by age categories .Age is calculated at cohort entry .Panel B .Parathyroidectomy rates by sex .Panel C .Parathyroidectomy rates for incident and prevalent patients .", "label": "", "metadata": {}, "score": "72.60632"}
{"text": "After six months of treatment , a statistically significant reduction in the mean serum levels of iPTH ( from 1388.3 ?461.7 to 435.0 ? 0.6 to 8.3 ? 1.2 to 3.8 ?", "label": "", "metadata": {}, "score": "72.65894"}
{"text": "Mean group baseline PTH levels ( pg / mL ) prior to dosing were : AMG 416 ( 667 ) , cinacalcet ( 949 ) , saline ( 1026 ) .", "label": "", "metadata": {}, "score": "72.670334"}
{"text": "PTH was measured by intact PTH assays at 4-week intervals .All centers were instructed to use the same type of PTH assay throughout the entire study period .", "label": "", "metadata": {}, "score": "72.72168"}
{"text": "( mg / week ) ; CC , Ca carbonate ( g / day ) ; S , sevelamer ( g / day ) ; C 30 ? , cinacalcet ( 30 mg every other day ) .", "label": "", "metadata": {}, "score": "72.77398"}
{"text": "In fact , some years ago we found that the BB polymorphic variant of Vitamin D receptor ( VDR ) gene was associated with lower prevalence of HC PT - HPT [ 13 ] .", "label": "", "metadata": {}, "score": "72.98091"}
{"text": "Dietary phosphorus intake , which is another determinant of serum FGF23 in CKD [ 24 , 25 ] could not be assessed in the present study .", "label": "", "metadata": {}, "score": "73.01198"}
{"text": "An aging population may lead to lower PTX rates while an increasing proportion of prevalent patients may increase PTX rates .However , the population characteristics did not change much during the study years and the same PTX trend pattern was seen among subgroups ( Figure 3 ) .", "label": "", "metadata": {}, "score": "73.12507"}
{"text": "In fact , though KTx patients often present a more or less severe vitamin D deficiency , there is much controversy on whether this deficit should be replaced even in the presence of elevated serum calcium levels .", "label": "", "metadata": {}, "score": "73.175385"}
{"text": "Miki H , Sumitomo M , Inoue H , Kita S , Monden Y. Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis .", "label": "", "metadata": {}, "score": "73.19449"}
{"text": "Female gender , non - diabetic cause of renal disease and age group 40 - 45 compared with younger and older patients , and cumulative time with functioning graft less than one year were all associated with higher risk for PTX .", "label": "", "metadata": {}, "score": "73.25506"}
{"text": "The secondary objective was to evaluate the professional practices .[ Show abstract ] [ Hide abstract ] ABSTRACT : Elevated parathyroid hormone levels may be associated with adverse clinical outcomes in patients on dialysis .", "label": "", "metadata": {}, "score": "73.27261"}
{"text": "Plasma PTH levels were quantified according to the manufacturer 's protocol using rat ( 1 - 84 ) bioactive intact PTH ELISA kits from Immutopics International ( Rat : # 60 - 2700 ; San Clemente , California ) .", "label": "", "metadata": {}, "score": "73.46455"}
{"text": "Conclusion .The rise in PTX rates after year 2000 might reflect increasing awareness of the potential benefits of PTX .The introduction of calcimimetics and paricalcitol might explain the decreased rate after 2005 .", "label": "", "metadata": {}, "score": "73.62285"}
{"text": "In addition , our follow - up period comprises different eras of treatment availability and modality .The fact that this study is based on an entire population with a wide geographical distribution within the country is to our knowledge a unique situation .", "label": "", "metadata": {}, "score": "73.66306"}
{"text": "Rx 8 .Rx 9 .Rx 10 .Rx 11 .Rx 12 .C , cinacalcet ( mg / day ) ; CTR , calcitriol per os ( mg / day ) ; CTRv , calcitriol i.v .", "label": "", "metadata": {}, "score": "73.679794"}
{"text": "Additional rodent studies document the changes to parathyroid gland biology that can take place with chronic AMG 416 treatment [ 5 ] , and the molecule 's effects on serum phosphorus levels have been shown in the clinical setting [ 6 , 13 ] .", "label": "", "metadata": {}, "score": "73.68607"}
{"text": "The pharmaceutical company Amgen ( Solna , Sweden ) provided aggregate data on the sales of cinacalcet ( Mimpara \u00ae ) per calendar year in Sweden .", "label": "", "metadata": {}, "score": "73.70203"}
{"text": "A mean of 1.3 \u00b1 0.8 ethanol injections was performed .Nodular volume was 1.5 \u00b1 1.7 cm(3 ) , and 2.8 \u00b1 2.8 cm(3 ) of ethanol was injected per patient .", "label": "", "metadata": {}, "score": "73.7305"}
{"text": "Determination of time - at - risk and follow - up .Start date was defined as date of registration in the SRR .Patients were censored at death , at PTX , when lost to follow - up , or at end of study .", "label": "", "metadata": {}, "score": "73.78172"}
{"text": "One of the few studies which explored the skeletal status in KTx by bone biopsy found that HC was indifferently associated to either the increased bone turnover disease or to the adynamic bone disease [ 16 ] .", "label": "", "metadata": {}, "score": "73.83925"}
{"text": "Using a provincial administrative database , we included all adult patients receiving chronic dialysis treatments between 2001 and 2010 ( incident and prevalent ) in a time series analysis .", "label": "", "metadata": {}, "score": "73.914795"}
{"text": "PubMed View Article .Jollis JG , Ancukiewicz M , DeLong ER , Pryor DB , Muhlbaier LH , Mark DB : Discordance of databases designed for claims payment versus clinical information systems .", "label": "", "metadata": {}, "score": "73.95965"}
{"text": "al showed a relatively constant PTX rate throughout the study period of 1983 and 1996 [ 5 ] .Kestenbaum et .al reported a slight rise in adjusted PTX rates between 1990 and 1995 with a subsequent decline of 30 % in 1999 [ 1 ] .", "label": "", "metadata": {}, "score": "73.97725"}
{"text": "Furthermore , some preliminary data of ours [ 23 ] seem to suggest that the higher the serum calcium levels , the higher the progression of VC after KTx .", "label": "", "metadata": {}, "score": "74.090904"}
{"text": "Parathyroidectomy Hyperparathyroidism , Secondary Calcimimetic agents Renal dialysis Epidemiologic studies .Background .Secondary hyperparathyroidism is a common and serious disease that develops early in chronic kidney disease and continues to progress after subjects reach dialysis .", "label": "", "metadata": {}, "score": "74.42854"}
{"text": "( A ) Plasma PTH measured at 6 , 16 and 48 hr from the last dose .( B ) Plasma PTH measured at 16 hr following dosing on Days 7 , 14 , 21 and 28 .", "label": "", "metadata": {}, "score": "74.50481"}
{"text": "However , from 2001 to 2004 the rate increased significantly , even after adjusting for patient characteristics , and showed a tendency to decrease from 2005 onwards .", "label": "", "metadata": {}, "score": "74.515274"}
{"text": "On December 31 , 2012 , 73,491 patients were receiving a RRT in France ( 1127 per million inhabitants , 56 % on dialysis and 44 % living with a functional renal transplant ) .", "label": "", "metadata": {}, "score": "74.54111"}
{"text": "A number of potential negative effects of HC on different tissues , organs , and systems have been extensively reported in the literature .In the following paragraphs , we will just limit ourselves to briefly mention the most relevant ones which can more frequently occur in KTx patients .", "label": "", "metadata": {}, "score": "74.562164"}
{"text": "PubMed View Article .Seiler S , Heine GH , Fliser D : Clinical relevance of FGF-23 in chronic kidney disease .Kidney Int Supplement 2009 , 114 : S34-S42 .", "label": "", "metadata": {}, "score": "74.6272"}
{"text": "In advanced CKD , FGF23 no longer maintains phosphate homeostasis and the suppression of 1,25(OH ) 2 D production exerted by FGF23 induces PTH elevation , resulting in secondary hyperparathyroidism ( SHPT ) .", "label": "", "metadata": {}, "score": "74.70714"}
{"text": "Hsu HJ , Wu MS : Fibroblast growth factor 23 : a possible cause of left ventricular hypertrophy in hemodialysis patients .Am J Med Sci 2009 , 337 : 116 - 122 .", "label": "", "metadata": {}, "score": "74.98888"}
{"text": "Conclusions .As a long - acting CaSR agonist suitable for administration by the IV route , AMG 416 is a potential new therapy for the treatment of CKD patients with SHPT receiving hemodialysis .", "label": "", "metadata": {}, "score": "75.01967"}
{"text": "Therefore , the indication for the PTX intervention is quite variable from one transplant centre to another .Furthermore , there is no general agreement on which type of PTX should be preferred : total , subtotal with or without the auto - transplantation of a parathyroid gland .", "label": "", "metadata": {}, "score": "75.05332"}
{"text": "Nihon Jinzo Gakkai Shi 1996 , 38 ( 7):309 - 313 .PubMed .Ganesh SK , Stack AG , Levin NW , Hulbert - Shearon T , Port FK : Association of elevated serum PO(4 ) , Ca x PO(4 ) product , and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients .", "label": "", "metadata": {}, "score": "75.06917"}
{"text": "Secondary , retrospective study may not include all patients enrolled initially .Patients who can not tolerate treatment or who withdrew because of any other reasons will be excluded .", "label": "", "metadata": {}, "score": "75.12754"}
{"text": "PTX was identified through linkage between the SRR cohort and SNIR , and between the SRR and the ( SQRTPA ) , by using the national personal identification number .", "label": "", "metadata": {}, "score": "75.14594"}
{"text": "The abdominal incision was then closed and the animal was allowed to recover for approximately 48 hrs prior to dosing .Animals were given free access to food and water .", "label": "", "metadata": {}, "score": "75.38"}
{"text": "PubMed .Schon S , Ekberg H , Wikstrom B , Od\u00e9n A , Ahlm\u00e9n J : Renal replacement therapy in Sweden .Scand J Urol Nephro 2004 , 38 ( 4):332 - 339 .", "label": "", "metadata": {}, "score": "75.46817"}
{"text": "Ludvigsson JF , Andersson E , Ekbom A , Feychting M , Kim JL , Reuterwall C , Heurgren M , Olausson PO : External review and validation of the Swedish national inpatient register .", "label": "", "metadata": {}, "score": "75.60419"}
{"text": "Conclusions .A decreased annual rate of PTX was found after January 2006 , corresponding to cinacalcet availability .However , decreased rates may be due to other factors occurring simultaneously with cinacalcet introduction and further studies are needed to confirm these findings .", "label": "", "metadata": {}, "score": "75.62303"}
{"text": "Finally , Table 3 shows individual results as far as biochemistry ( serum Ca , P and iPTH ) is concerned at three time - points ( at the baseline , at three and six months ) .", "label": "", "metadata": {}, "score": "75.665215"}
{"text": "Moreover , because the ARIMA model relied on time points and not on patient - level exposure , incomplete ascertainment of exposure does not influence our results .", "label": "", "metadata": {}, "score": "75.84609"}
{"text": "Table 2 .Univariate linear regression analysis for association of the percent change in square root FGF23 with other variables .Doses of medications and safety .", "label": "", "metadata": {}, "score": "75.85363"}
{"text": "In 2003 , KDOQI guidelines [ 19 ] recommended a maximum dose of 1500 mg / day of elemental calcium , which was significantly lower than the usual practice .", "label": "", "metadata": {}, "score": "75.96066"}
{"text": "Gutierrez OM , Mannstadt M , Isakova T , Rauh - Hain JA , Tamez H , Shah A , Smith K , Lee H , Thadhani R , Juppner H , Wolf M : Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis .", "label": "", "metadata": {}, "score": "76.1022"}
{"text": "View at Google Scholar \u00b7 View at Scopus .K. Gusev , A. A. Domenighetti , L. M. D. Delbridge , T. Pedrazzini , E. Niggli , and M. Egger , \" Angiotensin II - mediated adaptive and maladaptive remodeling of cardiomyocyte excitation - contraction coupling , \" Circulation Research , vol .", "label": "", "metadata": {}, "score": "76.559784"}
{"text": "Bimonthly rates of PTX are given in Figure 2 .The average rate before cinacalcet approval was 11.4 /1000 py and was 3.6 /1000 py after cinacalcet reimbursement .", "label": "", "metadata": {}, "score": "76.58806"}
{"text": "The linkage of three nation - wide registries with broad and accurate coverage further adds to the validity of the present results .Conclusion .PTX rates differed over time in Swedish patients on RRT .", "label": "", "metadata": {}, "score": "76.68663"}
{"text": "After 2006 , annual PTX rates remained between 3.0 and 4.6 /1000 py .While January 2006 was the only statistically significant cut - off point in our model , visually the change in rate appeared slightly before that and all cut - off dates between January 2005 and June 2006 showed a trend for a lower PTX rates .", "label": "", "metadata": {}, "score": "76.73872"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. A. Perazella and M. J. Bia , \" Posttransplant erythrocytosis : case report and review of newer treatment modalities , \" Journal of the American Society of Nephrology , vol .", "label": "", "metadata": {}, "score": "76.77227"}
{"text": "Scandinavian quality register for thyroid parathyroid and adrenal surgery .KDOQI : .Kidney disease outcomes quality initiative .Declarations .Acknowledgements .This study received grants from Maggie Stephens 's foundation , Lund University .", "label": "", "metadata": {}, "score": "76.88068"}
{"text": "Second generation human FGF23 ( C - terminal )ELISA kit ( Immutopics , San Clemente , California , USA ) was employed .The serum was diluted ten - fold with dilution reagent to measure C- terminal FGF23 , since the assay accuracy was not validated above this dilution level .", "label": "", "metadata": {}, "score": "76.893906"}
{"text": "Pathogenic Mechanisms of HC in KTx Patients .The first - well recognized factor in causing the occurrence of HC after KTx is the persistence of SHP after transplantation [ 11 , 13 ] .", "label": "", "metadata": {}, "score": "76.9579"}
{"text": "End stage renal disease Dialysis Renal transplantation Secondary hyperparathyroidism Parathyroidectomy .Background .Secondary hyperparathyroidism ( sHPT ) is a common complication of chronic kidney disease .", "label": "", "metadata": {}, "score": "77.67392"}
{"text": "Elefteriou F : Regulation of bone remodeling by the central and peripheral nervous system .Arch Biochem Biophys 2008 , 473 ( 2):231 - 236 .", "label": "", "metadata": {}, "score": "77.71657"}
{"text": "Serum concentrations of immunoassay calciumlevels\u00fe[(4.0 ?Page 3 .Statistical analyses The distribution of the data was studied by means of the Kolmogorov - Smirnov test : all of them were non - normally distributed .", "label": "", "metadata": {}, "score": "77.857315"}
{"text": "PEIT is an effective treatment to control recurrences of secondary hyperparathyroidism postsubtotal parathyroidectomy .[ Show abstract ] [ Hide abstract ] ABSTRACT : Secondary hyperparathyroidism ( high - turnover bone disease , or HTBD ) is manifested by elevated parathyroid hormone ( PTH ) levels .", "label": "", "metadata": {}, "score": "77.96387"}
{"text": ": Aim : Uremic hyperparathyroidism ( UHPT ) has been shown to contribute to the development and progression of chronic kidney disease - mineral bone disorder .", "label": "", "metadata": {}, "score": "78.09825"}
{"text": "Therefore , prevention and control of UHPT is crucial for dialysis patients as the excessive parathyroid hormone exerts systemic toxicity .During the past decades , treatment of UHPT has been more advanced and evolved based on new insights into its pathogenesis .", "label": "", "metadata": {}, "score": "78.26747"}
{"text": "Preliminary Communication Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy Carlo Lomonte , Maurizio Antonelli , Nicola Losurdo , Giovanni Marchio , Bernardo Giammaria and Carlo Basile Division of Nephrology , Miulli General Hospital , Acquaviva delle Fonti , Italy Abstract Background .", "label": "", "metadata": {}, "score": "78.32129"}
{"text": "Patient characteristics at baseline are shown in Table 1 .A total of 679 PTX were identified in 20,015 patients ( 3.4 % ) .The mean follow - up ( SD ) time for the whole cohort was 3.9 ( 4.1 ) years .", "label": "", "metadata": {}, "score": "78.34097"}
{"text": "PubMed View Article .Tokuyama K , Iseki K , Yoshi S , Yoshihara K , Nishime K , Uehara H , Tozawa M , Wake T , Arakaki M , Fukiyama K : An epidemiologic analysis of parathyroidectomy in chronic dialysis patients .", "label": "", "metadata": {}, "score": "78.40404"}
{"text": "PubMed View Article .Kidney Int 2011 , 79 : 1370 - 1378 .PubMed View Article .Circulation 2009 , 119 : 2545 - 2552 .", "label": "", "metadata": {}, "score": "78.43729"}
{"text": "42 ] , increased in 30 % of patients over the first year after KTx .Furthermore , patients heading for a progression of their VC process had consistently higher serum Calcium levels as compared with patients who did not have any VC worsening .", "label": "", "metadata": {}, "score": "78.59676"}
{"text": "Randomized controlled studies are needed for reaching a conclusive answer to this important question .Hematological Effects .After KTx ; increases in red blood cell number and in hemoglobin levels are not infrequently observed [ 43 ] .", "label": "", "metadata": {}, "score": "78.68442"}
{"text": "Ethical considerations .This study was approved by the Government of Qu\u00e9bec ethics committee ( Commission d'acc\u00e8s \u00e0 l'information ) and Maisonneuve - Rosemont Hospital ethics committee , and informed consent was waived .", "label": "", "metadata": {}, "score": "78.80884"}
{"text": "Of these , 126 were also found among the hospital admission data .A total of 956 PTX were identified .We defined an incident PTX as the first PTX occurring after registration in the SRR .", "label": "", "metadata": {}, "score": "78.946144"}
{"text": "Of the remaining 727 PTX , 41 were in patients with two operations , and 7 in patients with three operations , during the study period .", "label": "", "metadata": {}, "score": "79.07712"}
{"text": "Furthermore , it is still to be demonstrated which is the threshold calcium concentration , if any , over which these negative effects can happen .", "label": "", "metadata": {}, "score": "79.078766"}
{"text": "These 12 haemodialysis patients ( all of them more than 18 years old and clinically stable ) were enrolled into the present study after written informed consent .", "label": "", "metadata": {}, "score": "79.200485"}
{"text": "KDIGO clinical practice guideline for the diagnosis , evaluation , prevention , and treatment of Chronic Kidney Disease - Mineral and Bone Disorder ( CKD - MBD )", "label": "", "metadata": {}, "score": "79.33253"}
{"text": "In all the other cases , we do not believe that there is any compelling indication to PTX .A second critical point is the management of PT - HPT associated with HC .", "label": "", "metadata": {}, "score": "79.456375"}
{"text": "Full - text \u00b7 Article \u00b7 Dec 2014 \u00b7 Clinical Journal of the American Society of Nephrology .It is relying on a network of nephrologists , epidemiologists , patients and public health representatives .", "label": "", "metadata": {}, "score": "79.54135"}
{"text": "[5 ] described PTX rates in the US from 1992 to 2007 .A PTX peak rate was found in 2002 ( 12.8 /1000 py ) followed by a decreasing rate until 2005 ( 5.4 /1000 py ) and then an increase again in 2006 - 2007 ( 8.6 /1000 py ) [ 5 ] .", "label": "", "metadata": {}, "score": "79.67144"}
{"text": "10 , pp .1768 - 1773 , 2002 .View at Google Scholar .C. M. O'Seaghdha , Q. Yang , N. L. Glazer , et al . , \" Common variants in the calcium - sensing receptor gene are associated with total serum calcium levels , \" Human Molecular Genetics , vol .", "label": "", "metadata": {}, "score": "79.6969"}
{"text": "Another possible confounder in the evaluation of the real prevalence of HC in transplanted patients is the different methodology used for calcium assessment .In fact , it has been reported that elevated Ca levels might be often overlooked if evaluated as total serum Ca rather than ionized serum Ca , since the former underestimates HC in KTx patients [ 12 ] .", "label": "", "metadata": {}, "score": "79.77252"}
{"text": "They found that the adjusted PTX rate increased in 1998 , peaked in 2002 and decreased through 2005 with a new increase in 2006 and 2007 [ 3 ] .", "label": "", "metadata": {}, "score": "79.77486"}
{"text": "Policies for reimbursement of drugs vary by provinces .For the provincial drug plan in Qu\u00e9bec , decision to reimburse or not a drug is recommended by a provincial committee from the Institut national d'excellence en sant\u00e9 et en services sociaux ( INESSS ) , which evaluates its cost - effectiveness ratio and possible financial burden .", "label": "", "metadata": {}, "score": "79.78429"}
{"text": "Ritter CS , Pande S , Krits I , Slatopolsky E , Brown AJ : Destabilization of parathyroid hormone mRNA by extracellular Ca2 + and the calcimimetic R-568 in parathyroid cells : role of cytosolic Ca and requirement for gene transcription .", "label": "", "metadata": {}, "score": "79.9345"}
{"text": "Trends and current rates of PTX on a national level are not known .Furthermore , it is not completely clear which factors influence rates of PTX .", "label": "", "metadata": {}, "score": "79.93948"}
{"text": "No significant difference was noted in levels of alkaline phosphatase , hemoglobin , and albumin between the two groups .Goal Attainment of K / DOQI and KDIGO .", "label": "", "metadata": {}, "score": "79.96499"}
{"text": "480 - 482 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. O'Rourke , \" The ins and outs of calcium in heart failure , \" Circulation Research , vol .", "label": "", "metadata": {}, "score": "80.00189"}
{"text": "Baseline Characteristics between Different Treatment Groups ( Table 1 ) .Table 1 shows the baseline demographic and laboratory parameters of enrolled patients .Among 81 subjects , approximately three - quarters had severe UHPT ( defined as having an iPTH level greater than 800 pg / mL ) and one - quarter of the patients had moderate UHPT ( defined as iPTH between 500 and 800 pg / mL ) .", "label": "", "metadata": {}, "score": "80.11609"}
{"text": "All authors declare that they have no competing interests .Authors ' contributions .HJK participated in the design of the study , reviewed and collected data using e - CRF and electronic medical records system , performed the statistical analysis , and drafted the manuscript .", "label": "", "metadata": {}, "score": "80.18058"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Background Recommendations for secondary hyperparathyroidism ( SHPT ) consider that a \" one - size - fits - all \" target enables efficacy of care .", "label": "", "metadata": {}, "score": "80.46721"}
{"text": "Furthermore , FGF23 elevation is associated with increased mortality in CKD and ESRD patients [ 11 ] .Therefore , in CKD patients , modulation of FGF23 could possibly be a therapeutic target in preventing morbidity and mortality .", "label": "", "metadata": {}, "score": "80.49092"}
{"text": "Animals were allowed to recover for 9 - 10 days following surgery prior to dosing .Thirty - six animals were included in the study .", "label": "", "metadata": {}, "score": "80.540855"}
{"text": "[ Google Scholar ] [ CrossRef ] .Block , G.A. ; Martin , K.J. ; de Francisco , A.L. ; Turner , S.A. ; Avram , M.M. ; Suranyi , M.G. ; Hercz , G. ; Cunningham , J. ; Abu - Alfa , A.K. ; Messa , P. ; et al .", "label": "", "metadata": {}, "score": "80.62715"}
{"text": "The investigators of the CUPID Study finished the recruitment prematurely before target number of enrollment was reached .This was because enrollment was delayed due to lack of subjects who fulfilled the strict inclusion criteria .", "label": "", "metadata": {}, "score": "80.69089"}
{"text": "The evolution of idiopathic membranous membranous ( MNi ) is variable , treatment is discussed .Our work 's main objective was to evaluate the results of a standardized management strategy proposed in 2006 in Lorraine ( Nephrolor health network ) .", "label": "", "metadata": {}, "score": "80.6984"}
{"text": "Prevalence of HC after KTx .Table 1 shows the main characteristics of some of the most relevant studies , reporting on HC prevalence after KTx .", "label": "", "metadata": {}, "score": "80.88614"}
{"text": "A total of 66 patients were enrolled and randomly assigned at 1:1 ratio - 33 were assigned to the cinacalcet group and 33 to the control group .", "label": "", "metadata": {}, "score": "80.90869"}
{"text": "Calcium - sensing receptor Secondary hyperparathyroidism ( SHPT )Chronic kidney disease ( CKD ) Uremic rat model AMG 416 .Background .Chronic kidney disease ( CKD ) is a condition characterized by a gradual loss of kidney function .", "label": "", "metadata": {}, "score": "80.98527"}
{"text": "Error bars denote interquartile range ( A ) , or standard deviation ( SD ) ( B , C , D ) .iPTH , intact parathyroid hormone ; Ca , calcium ; P , phosphorus .", "label": "", "metadata": {}, "score": "81.00589"}
{"text": "The 1K1C model was based on the original model developed by Goldblatt [ 8 ] .The study protocol was approved by the Institutional Animal Care and Use Committee ( IACUC ) of KAI Pharmaceuticals , Inc. General anesthesia was induced and maintained by intraperitoneal ( IP ) injection of sodium pentobarbital ( 5.2 % , 0.4 mL / rat ) .", "label": "", "metadata": {}, "score": "81.25006"}
{"text": "The PTX rate was significantly higher in the years 2001 through 2004 .In the subsequent years following year 2005 , there was a decrease in the PTX rate , although this change did not reach statistical significance as compared with the reference year 2000 , Figure 1 , Table 4 .", "label": "", "metadata": {}, "score": "81.25677"}
{"text": "KYN , YLK , DK , JHC , YRS , and YHH participated in the design of the study , patient enrollment , acquisition of data , analysis , and interpretation of data .", "label": "", "metadata": {}, "score": "81.32649"}
{"text": "The cumulative sum of time spent with a functioning transplant in all transplant episodes was calculated .The term zero time with a functioning graft was used for patients who never received a transplant or in whom the transplant failed to function at start .", "label": "", "metadata": {}, "score": "81.39136"}
{"text": "The Poisson model goodness of fit was evaluated by comparison with negative binomial models .Unadjusted , aggregate sales of cinacalcet were graphically compared to unadjusted PTX rates for the years 2005 - 2009 .", "label": "", "metadata": {}, "score": "81.40555"}
{"text": "[ Google Scholar ] [ CrossRef ] .Clin .Am .Soc .Nephrol .[ Google Scholar ] [ CrossRef ] .Block , G.A. ; Zeig , S. ; Sugihara , J. ; Chertow , G.M. ; Chi , E.M. ; Turner , S.A. ; Bushinsky , D.A ; TARGET Investigators .", "label": "", "metadata": {}, "score": "81.65689"}
{"text": "PubMed .Mayo NE , Goldberg MS , Levy AR , Danys I , Korner - Bitensky N : Changing rates of stroke in the province of Quebec , Canada : 1981 - 1988 .", "label": "", "metadata": {}, "score": "81.74504"}
{"text": "JJ performed the 1K1C study .ES optimized the 1K1C surgical procedure .JD performed the 1K1C surgical procedure .QY synthesized peptides used for the studies .", "label": "", "metadata": {}, "score": "81.81094"}
{"text": "Chem .[ Google Scholar ] .Krajisnik , T. ; Bj\u00f6rklund , P. ; Marsell , R. ; Ljunggren , O. ; Akerstr\u00f6m , G. ; Jonsson , K.B. ; Westin , G. ; Larsson , T.E. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha - hydroxylase expression in cultured bovine parathyroid cells .", "label": "", "metadata": {}, "score": "81.887314"}
{"text": "Shimada T , Hasegawa H , Yamazaki Y , Muto T , Hino R , Takeuchi Y , Fujita T , Nakahara K , Fukumoto S , Yamashita T : FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis .", "label": "", "metadata": {}, "score": "81.89001"}
{"text": "This study included data from three prospective , population based , national registries .Ethical approval .The study was approved by the Regional Ethics Committee of Lund , DNR 2010/483 .", "label": "", "metadata": {}, "score": "82.07912"}
{"text": "Authors ' Affiliations .MedImmune .References .Brown EM , Gamba G , Riccardi D , Lombardi M , Butters R , Kifor O , Sun A , Hediger MA , Lytton J , Hebert SC : Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid .", "label": "", "metadata": {}, "score": "82.24577"}
{"text": "There were 12 795 patients on maintenance dialysis in Qu\u00e9bec between January 1 , 2001 and December 31 , 2010 .Derivation of the study cohort is detailed in Figure 1 .", "label": "", "metadata": {}, "score": "82.277306"}
{"text": "The SRR is a national web - based quality registry for patients on maintenance RRT [ 9 ] .Out of 20,056 eligible patients , we excluded 13 patients due to errors in reporting .", "label": "", "metadata": {}, "score": "82.29971"}
{"text": "Soc .Nephrol .[ Google Scholar ] .Fukagawa , M. ; Yumita , S. ; Akizawa , T. ; Uchida , E. ; Tsukamoto , Y. ; Iwasaki , M. ; Koshikawa , S. ; KRN1493 study group .", "label": "", "metadata": {}, "score": "82.36829"}
{"text": "Urakawa I , Yamazaki Y , Shimada T , Iijima K , Hasegawa H , Okawa K , Fujita T , Fukumoto S , Yamashita T : Klotho converts canonical FGF receptor into a specific receptor for FGF23 .", "label": "", "metadata": {}, "score": "82.81755"}
{"text": "Before islet transplantation , 10 patients ( 59 % ) were screened positive for IA .Conclusion : After islet transplantation , IA - positive patients achieved insulin independence less frequently , exhibiting lower \u03b2 score and higher homeostatic model assessment insulin resistance compared with IA - negative patients .", "label": "", "metadata": {}, "score": "82.855194"}
{"text": "\" [ Show abstract ] [ Hide abstract ] ABSTRACT : We evaluated the efficacy of percutaneous ethanol injection therapy ( PEIT ) as a therapeutic option for recurrence of secondary hyperparathyroidism after subtotal parathyroidectomy in ESRD patients .", "label": "", "metadata": {}, "score": "83.56844"}
{"text": "Secondly , the patient cohorts studied are heterogenous , often comprising subgroups of RRT patients [ 1 - 4 ] .Our study comprises all RRT patients in Sweden and covers the period before and after key publications on the consequences of sHPT on mortality and cardiovascular risk [ 13 - 16 ] and after the publication of the KDOQI guidelines for PTX [ 17 ] .", "label": "", "metadata": {}, "score": "83.61029"}
{"text": "cellulosic membrane with a surface area ranging from 1.5 to 2.0m2was utilized ; dialysate and blood flows were respec- tively 500 and 300ml / min .", "label": "", "metadata": {}, "score": "83.78329"}
{"text": "YSK and CA participated in conception of the study , acquisition of data , and helped to draft the manuscript .KHO had made substantial contributions to conception and design of the study , and draft and revision of the manuscript .", "label": "", "metadata": {}, "score": "83.86058"}
{"text": "The mean values of corrected Ca , P , and corrected Ca \u00d7 P during assessment period were calculated to analyze the results .Statistical analysis .", "label": "", "metadata": {}, "score": "84.09863"}
{"text": "Uremic hyperparathyroidism ( UHPT ) is one of the complications of chronic kidney disease ( CKD ) and is more commonly observed in patients undergoing dialysis .", "label": "", "metadata": {}, "score": "84.214966"}
{"text": "PubMed .Levy AR , Mayo NE , Grimard G : Rates of transcervical and pertrochanteric hip fractures in the province of Quebec , Canada , 1981 - 1992 .", "label": "", "metadata": {}, "score": "84.42863"}
{"text": "Measured serum Ca levels were adjusted by albumin levels as follows , when they were less than 4.0g / dl : Calcium\u00bcmeasured levels ) ? 0.8 ] mg / dl [ 16].", "label": "", "metadata": {}, "score": "84.45633"}
{"text": "CKD is often further complicated by the development of secondary hyperparathyroidism ( SHPT ) due to these disturbances in mineral metabolism [ 1 ] .Increased PTH secretion in response to hypocalcemia is mediated by the calcium - sensing receptor ( CaSR ) a G - protein coupled receptor ( GPCR ) located on the parathyroid glands [ 2 ] .", "label": "", "metadata": {}, "score": "84.501114"}
{"text": "55.4SD months ( range 64 - 240 ) .These patients had mean serum iPTH levels of 996.2 ?53.8pg / ml ( range 370.4 - 1800.2 ) .", "label": "", "metadata": {}, "score": "84.57706"}
{"text": "This study compared the evolution of incident MNi between 2002 and 2005 ( Before ) and between 2007 and 2010 ( After ) , the respective dates point to 31/12/2011 and 31/12/2006 .", "label": "", "metadata": {}, "score": "84.603485"}
{"text": "KGP : General secreterary of the Swedish Renal Registry with operative responsibility for the validity of the Registry 's data , providing intellectual content of critical importance .", "label": "", "metadata": {}, "score": "85.044914"}
{"text": "Acknowledgements .We thank David Martin for his assistance compiling this manuscript .Competing interests .S. Alexander , D. Maclean and F. Karim are employees of Amgen and receive salary and/or own or have an interest in Amgen stock .", "label": "", "metadata": {}, "score": "85.521576"}
{"text": "Ann Intern Med 1993 , 119 ( 8) : 844 - 850 .PubMed View Article .Tamblyn R , Reid T , Mayo N , McLeod P , Churchill - Smith M : Using medical services claims to assess injuries in the elderly : sensitivity of diagnostic and procedure codes for injury ascertainment .", "label": "", "metadata": {}, "score": "86.237305"}
{"text": "In Canada , a new drug can not be marketed before being approved by Health Canada , which evaluates efficacy and safety of the drug .", "label": "", "metadata": {}, "score": "86.33849"}
{"text": "The mean annual incidence of first PTx is about 30 per 1000 patient years in those dialysis patients treated for more than 10 years [ 3].", "label": "", "metadata": {}, "score": "86.35686"}
{"text": "Results .The PTX rate was 8.8/1 000 person - years .There was a significant increase 2001 - 2004 after which the rate fell , as compared with year 2000 .", "label": "", "metadata": {}, "score": "86.45981"}
{"text": "Abbreviations : Ca , calcium - containing phosphate binders ; Mg , magnesium - containing phosphate binders ; Al , aluminum - containing phosphate binders .", "label": "", "metadata": {}, "score": "86.46338"}
{"text": "Baseline values ' of the various biochemical tests - Ca , P , iPTH , etc . - were defined as those measured after washout period ( post - washout ) .", "label": "", "metadata": {}, "score": "86.55461"}
{"text": "Keywords .Cinacalcet Fibroblast growth factor 23 Peritoneal dialysis .Background .Fibroblast growth factor-23 ( FGF23 ) is an endocrine hormone that regulates phosphate and vitamin D homeostasis .", "label": "", "metadata": {}, "score": "86.66467"}
{"text": "In opposition to ARIMA models , Poisson regression does not account for the dependence between measures seen in our situation ( a patient may be present in different intervals ) , but its results are more intuitive and may help validate results from ARIMA .", "label": "", "metadata": {}, "score": "87.06305"}
{"text": "It has been well acknowledged for some time that acute changes in extracellular calcium concentration might induce consensual changes of intracellular calcium levels which are the ultimate controller of cardiomyocyte and vascular smooth muscle cell contraction and relaxation [ 37 - 39 ] .", "label": "", "metadata": {}, "score": "87.51734"}
{"text": "Methods .Study population and data sources .This study was conducted using the R\u00e9gie de l'assurance maladie du Qu\u00e9bec ( RAMQ ) database in the province of Qu\u00e9bec , Canada .", "label": "", "metadata": {}, "score": "87.59271"}
{"text": "al reported a progressive decline from 1992 to 1998 with an increase in 2002 [ 2 ] .There are several possible explanations for this reported diversity in PTX rates .", "label": "", "metadata": {}, "score": "87.60359"}
{"text": "Authors ' Affiliations .Department of Nephrology , Clinical Sciences Lund , Lund University , Alwallhuset .Department of Nephrology , Clinical Sciences Malm\u00f6 , Lund University .", "label": "", "metadata": {}, "score": "87.70161"}
{"text": "Autoregressive integrated moving average ( ARIMA ) intervention models were used to analyze the effect of cinacalcet availability on PTX rates .The ARIMA intervention model is a specific time series model .", "label": "", "metadata": {}, "score": "87.7073"}
{"text": "PTX was the primary outcome and was identified through hospital discharge summary procedure codes ( CCP : 19.71 , 19.72 ; CCI : 1FV83 , 1FV87 , 1FV89 ) and RAMQ physician claim code ( 6186 , 6185 , 6181 ) .", "label": "", "metadata": {}, "score": "87.78026"}
{"text": "We are grateful to Ms Bjorkman at the Swedish National Board of Health and Welfare for help with data requisition and for Amgen , Sweden , for providing aggregate data on sales of cinacalcet .", "label": "", "metadata": {}, "score": "87.81073"}
{"text": "Recipients received a total islet mass of 9,715.75 \u00b1 3,444.40 islet equivalents / kg .Thirty - four patients completed a 5-year follow - up , and 10 patients completed a 4-year follow - up .", "label": "", "metadata": {}, "score": "87.89145"}
{"text": "Competing interests .This work was supported by an unrestricted grant from Amgen Canada .Dr. Lafrance is supported by a KRESCENT New Investigator Award ( public funding ) and has received advisory - board and lecture fees from Amgen Canada for unrelated work .", "label": "", "metadata": {}, "score": "88.54091"}
{"text": "Considering pretransplant immune profile may help to select those patients who may benefit from ATG to prevent severe infections and acute rejection .\u00a9 Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons .", "label": "", "metadata": {}, "score": "88.72102"}
{"text": "FGF23 could be a better prognosis predictor of cardiovascular disease than any other biomarkers .Therefore , reduction of FGF23 may become a novel target of treating SHPT for lowering cardiovascular risk and improving prognosis of CKD patients .", "label": "", "metadata": {}, "score": "89.03537"}
{"text": "Email : basile.miulli@libero.it Nephrol Dial Transplant ( 2007 ) 1 of 7 doi:10.1093/ndt / gfm156 ?The Author [ 2007].Published by Oxford University Press on behalf of ERA - EDTA .", "label": "", "metadata": {}, "score": "89.243576"}
{"text": "Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "89.54405"}
{"text": "In 2012 , in France , 10,048 patients started a RRT ( 154 per million inhabitants ) .Elders provided majority of new patients ( median age at RRT start : 70 years old ) .", "label": "", "metadata": {}, "score": "90.395294"}
{"text": "All statistical inferences were performed using the SPSS software package , version 10 ( SPSS Inc. , Chicago , IL , USA ) .Results The clinical and demographic characteristics of the two groups are shown in Table 1 .", "label": "", "metadata": {}, "score": "90.622894"}
{"text": "Median parathyroid hormone increased from phase 1 to phase 4 in all regions except for Japan , where it remained stable .Prescriptions of intravenous vitamin D analogs and cinacalcet increased and parathyroidectomy rates decreased in all regions over time .", "label": "", "metadata": {}, "score": "90.957146"}
{"text": "Conclusion In real life , dialysis patients with newly diagnosed SHPT constitute a very heterogeneous population .A \" one - size - fits - all \" target approach is probably not appropriate .", "label": "", "metadata": {}, "score": "91.48177"}
{"text": "Fifty percent were treated with IS respecting strategy .Despite differences between the strategy and practices , which may explain these non - significant results , we observed changes in thinking and therapeutic attitude of the clinician .", "label": "", "metadata": {}, "score": "91.7319"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT :The evolution of idiopathic membranous membranous ( MNi ) is variable , treatment is discussed .", "label": "", "metadata": {}, "score": "91.796844"}
{"text": "The iPTH was determined using direct chemiluminescent immunoassay ( Intact PTH ; Siemens Healthcare Diagnostics , INC , Erlangen , Germany ) with a normal range of 12 - 72 pg / mL. Serum calcium and phosphorous levels were analyzed by an onsite laboratory using standard methods .", "label": "", "metadata": {}, "score": "91.945076"}
{"text": "All statistical analyses were performed using the SPSS software ( version 18.0 . , SPSS Inc , Chicago , III , USA ) .Results .", "label": "", "metadata": {}, "score": "91.94946"}
{"text": "Canadian Institute for Health Information : Treatment of End - Stage Organ Failure in Canada , 2000 to 2009 ( 2011 Annual Report ) .Ottawa : CIHI ; 2011 .", "label": "", "metadata": {}, "score": "92.42616"}
{"text": "Calcium sensing receptor .SD : .Standard deviation .Q : .Quartile .CI : .Confidence interval .p.o : .Per os .", "label": "", "metadata": {}, "score": "92.73024"}
{"text": "FGF23 inhibits phosphate reabsorption in the renal tubule and promotes phosphaturia by down - regulating sodium - phosphate co - transporters [ 3 ] .It decreases renal production of 1,25(OH ) 2 D by inhibiting 1\u03b1 - hydroxylase and up - regulating 24-hydroxylase in the proximal tubule [ 3 , 4 ] .", "label": "", "metadata": {}, "score": "93.06025"}
{"text": "SQRTPA was launched in 2004 and the coverage 2010 was 90 % .In general , less than five percent of patients were not registered or incorrectly registered .", "label": "", "metadata": {}, "score": "93.49538"}
{"text": "J. Med .[ Google Scholar ] [ CrossRef ] .Shoji , T. ; Shinohara , K. ; Kimoto , E. ; Emoto , M. ; Tahara , H. ; Koyama , H. ; Inaba , M. ; Fukumoto , S. ; Ishimura , E. ; Miki , T. ; et al .", "label": "", "metadata": {}, "score": "93.75058"}
{"text": "PubMed View Article .J Am Soc Nephrol 2007 , 18 : 2600 - 2608 .PubMed View Article .JAMA 2011 , 305 : 2432 - 2439 .", "label": "", "metadata": {}, "score": "94.42296"}
{"text": "MA : Conception and design , responsible for the epidemiological design , analysis and interpretation of the data , drafting and revising , providing intellectual content of critical importance .", "label": "", "metadata": {}, "score": "94.65557"}
{"text": "The authors declare that they have no competing interests .Authors ' contributions .SA : Conception and design , analysis and interpretation of the data , drafting and revising the article , interpretation of the results , providing intellectual content of critical importance .", "label": "", "metadata": {}, "score": "95.74744"}
{"text": "Allocation : Randomized Endpoint Classification : Efficacy Study Intervention Model : Parallel Assignment Masking : Double Blind ( Subject , Caregiver , Investigator )Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "95.796036"}
{"text": "More recently , a genome - wide association study ( GWAS ) has clearly demonstrated that a single nucleotide polymorphism in the gene coding for the calcium sensing receptor ( CaSR ) is strongly associated with the levels of serum calcium in the general population [ 28 ] .", "label": "", "metadata": {}, "score": "96.272804"}
{"text": "National Registry Centre , Skane University Hospital .Department of Internal Medicine , Helsingborg Hospital .Section of Endocrine and Sarcoma Surgery , Department of Surgery , Skane University Hospital .", "label": "", "metadata": {}, "score": "96.7162"}
{"text": "BR : Chairperson of the Swedish Renal Registry and responsible for the Registry 's validity , providing intellectual content of critical importance .Final approval .", "label": "", "metadata": {}, "score": "96.79668"}
{"text": "P\u00bcnot significant .Table 2 . 6.9 NS 0.01 0.017 0.08 0.01 NS 0.021 0.01 0.032 47.7 ? 0.6 0.007 0.01 NS NS NS Both Wilcoxon test for paired data ( ?", "label": "", "metadata": {}, "score": "96.914795"}
{"text": "Division of Nephrology , Department of Internal Medicine , Kaohsiung Chang Gung Memorial Hospital , Chang Gung University College of Medicine , Kaohsiung , 833 , Taiwan .", "label": "", "metadata": {}, "score": "96.9593"}
{"text": "Choosing to participate in a study is an important personal decision .Talk with your doctor and family members or friends about deciding to join a study .", "label": "", "metadata": {}, "score": "96.97739"}
{"text": "Final approval .PW : Responsible for the design of the statistical analyses .Final approval .RR : Responsible for the design and execution of the statistical analyses .", "label": "", "metadata": {}, "score": "97.499016"}
{"text": "Endocrinol .Metab .[ Google Scholar ] [ CrossRef ] .Endocrinology 1998 , 139 , 4391 - 4396 .[ Google Scholar ] [ CrossRef ] .", "label": "", "metadata": {}, "score": "97.77674"}
{"text": "Authors ' contributions .All authors have approved the final version .Authors ' Affiliations .Centre de recherche H\u00f4pital Maisonneuve - Rosemont .D\u00e9partement de M\u00e9decine , Universit\u00e9 de Montr\u00e9al .", "label": "", "metadata": {}, "score": "98.01398"}
{"text": "DBM oversaw study design and interpretation of data .FK oversaw study design , data interpretation and contributed to the writing of the manuscript .RJ oversaw study design .", "label": "", "metadata": {}, "score": "98.108734"}
{"text": "Design .Multicenter , open - labeled , randomized controlled study .Setting .Seven university - affiliated hospitals in Korea .Participants .Overall , 66 peritoneal dialysis patients were enrolled .", "label": "", "metadata": {}, "score": "98.19839"}
{"text": "Copyright \u00a9 2014 Association Soci\u00e9t\u00e9 de n\u00e9phrologie .Published by Elsevier SAS .All rights reserved .[ Show abstract ] [ Hide abstract ] ABSTRACT : Background : In patients with type 1 diabetes , insulin antibodies ( IA ) , altering the pharmacokinetics of circulating insulin , might be associated with high glucose concentration , prolonged hypoglycemia , and higher insulin requirement .", "label": "", "metadata": {}, "score": "98.71507"}
{"text": "PubMed View Article .Nature 1997 , 390 : 45 - 51 .PubMed View Article .J Biol Chem 2003 , 278 : 2206 - 2211 .", "label": "", "metadata": {}, "score": "98.898026"}
{"text": "PubMed View Article .Pre - publication history .Copyright .\u00a9 Lafrance et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd. all Addendum Article Book Review Case Report Comment Commentary Communication Concept Paper Conference Report Correction Creative Data Descriptor Discussion Editorial Erratum Essay Interesting Images Letter New Book Received Obituary Opinion Project Report Reply Retraction Review Short Note Technical Note .", "label": "", "metadata": {}, "score": "99.26468"}
{"text": "41 , no .4 , pp .285 - 290 , 1991 .View at Google Scholar \u00b7 View at Scopus Abstract .Background .", "label": "", "metadata": {}, "score": "99.4814"}
{"text": "The percent change was calculated for each mineral metabolic parameter with the following formula : [ ( week 16 measurement - baseline measurement)/baseline measurement ] \u00d7 100 .", "label": "", "metadata": {}, "score": "99.796524"}
{"text": "RDF+N3 RDF+XML Refer Reference Manager Simple Metadata XMLforCMS2", "label": "", "metadata": {}, "score": "100.14184"}
{"text": "PubMed View Article .Hipel KW , McLeod AI : Time Series Modelling of Water Resources and Environmental Systems .Amsterdam : Elsevier Scientific Publishing Company ; 1994 .", "label": "", "metadata": {}, "score": "100.34259"}
{"text": "PubMed View Article .N Engl J Med 2004 , 350 ( 15):1516 - 1525 .PubMed View Article .J Pharm Exp Ther 2004 , 308 ( 2):627 - 635 .", "label": "", "metadata": {}, "score": "100.40782"}
{"text": "Statistical analysis was performed using SPSS version 17.0 ( SPSS Inc. , Chicago , IL ) .All categorical data were provided for absolute counts or percentages , whereas mean value \u00b1 standard deviation ( SD ) was presented as continuous data .", "label": "", "metadata": {}, "score": "101.88127"}
{"text": "Authors ' contributions .SW wrote the manuscript and contributed to the design of the studies .AB conceived of the studies and aided in data interpretation .", "label": "", "metadata": {}, "score": "102.09274"}
{"text": "Results are presented as mean \u00b1 SD for normally distributed variables and median [ interquartile range ( IQR ) ] for variables with skewed distributions .", "label": "", "metadata": {}, "score": "102.25238"}
{"text": "Nephrol .Dial .Transplant .[ Google Scholar ] .Nephrol .Dial .Transplant .[ Google Scholar ] [ CrossRef ] .National Kidney Foundation .", "label": "", "metadata": {}, "score": "102.58645"}
{"text": "Soc .Nephrol .[ Google Scholar ] [ CrossRef ] .JAMA 2011 , 305 , 1119 - 1127 .[ Google Scholar ] .", "label": "", "metadata": {}, "score": "103.978195"}
{"text": "4 , pp .558 - 566 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .5 , no .", "label": "", "metadata": {}, "score": "104.778336"}
{"text": "4 , pp .329 - 335 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .132 , no . 2 , pp .", "label": "", "metadata": {}, "score": "105.15372"}
{"text": "NC : Interpretation of the results , revising the article , providing intellectual content of critical importance .Final approval .GS : Revising the article , providing intellectual content of critical importance .", "label": "", "metadata": {}, "score": "105.33722"}
{"text": "Authors ' Affiliations .Department of Internal Medicine , Seoul National University .Department of Internal Medicine , Seoul National University Bundang Hospital .Department of Internal Medicine , Kyungpook National University .", "label": "", "metadata": {}, "score": "105.63202"}
{"text": "8306 ) ; Fax : +886 - 7 - 732 - 2402 .Received : 16 February 2013 ; in revised form : 25 March 2013 / Accepted : 7 April 2013 / Published : 19 April 2013 .", "label": "", "metadata": {}, "score": "105.97354"}
{"text": "We thank the Medical Research Collaborating Center ( MRCC ) , Seoul National University Hospital for the statistical advice .Funding .Funded by Kyowa Kirin , Korea .", "label": "", "metadata": {}, "score": "106.77604"}
{"text": "7.3mg2/dl2 ; Table 1 .31.3 Controls 7 8 9 10 11 12 M F F M M M 24 64 51 47 48 45 48.2 ?", "label": "", "metadata": {}, "score": "107.748825"}
{"text": "Acknowledgments .The CUPID study was funded by Kyowa Kirin , Korea .However , the funding body had no role in the design , implementation , analysis of the study .", "label": "", "metadata": {}, "score": "108.1788"}
{"text": "Department of Internal Medicine , Gachon University .Department of Internal Medicine , Hallym University .Department of Internal Medicine , Eulji University .Medical Research Collaborating Center , Seoul National University Hospital .", "label": "", "metadata": {}, "score": "109.46849"}
{"text": "FGF23 is synthesized and released by bone cells , mainly osteocytes [ 1 , 2 ] .Osteocyte and osteoblast were shown to express calcium sensing receptor ( CaSR ) .", "label": "", "metadata": {}, "score": "110.06789"}
{"text": "Readers may use this article as long as the work is properly cited , the use is educational and not for profit , and the work is not altered .", "label": "", "metadata": {}, "score": "114.18423"}
{"text": "Rx 4 .Rx 5 .Rx 6 .\u00fe S 3.2\u00feCC 1 9.5 C 60\u00feS 2.4 4.2 4008.2 C 30\u00feCTR 0.25\u00feCC 1 7.7 C 30\u00feCTR 0.25\u00feCC 2 7.5 C 30\u00feCTR 0.25\u00feCC 2 8.3 C 30\u00feCTR 0.25\u00feCC 1 9.0 C 30 ?", "label": "", "metadata": {}, "score": "115.08449"}
{"text": "We encourage to generalize the application of this strategy and to continue this cohort follow .Copyright \u00a9 2014 Association Soci\u00e9t\u00e9 de n\u00e9phrologie .Published by Elsevier SAS .", "label": "", "metadata": {}, "score": "116.02075"}
{"text": "Service de n\u00e9phrologie , Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al .Service de n\u00e9phrologie , H\u00f4pital du Sacr\u00e9 - C\u0153ur de Montr\u00e9al .Centre de recherche Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al .", "label": "", "metadata": {}, "score": "116.60477"}
{"text": "For Permissions , please email : journals.permissions@oxfordjournals.org .Page 2 . frequent ranging from 10 % after 3 years to 30 % after 7 years [ 4].", "label": "", "metadata": {}, "score": "117.520065"}
{"text": "Copyright .\u00a9 Akaberi et al . ; licensee BioMed Central Ltd. 2014 .This article is published under license to BioMed Central Ltd. Abstract .", "label": "", "metadata": {}, "score": "122.99408"}
{"text": "PubMed View Article .Pre - publication history .Copyright .\u00a9 Walter et al . ; licensee BioMed Central Ltd. 2014 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "123.004196"}
{"text": "Pre - publication history .Copyright .\u00a9 Kim et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "124.11276"}
{"text": "Received 24 January 2011 ; Revised 31 March 2011 ; Accepted 20 April 2011 .Academic Editor : Markus Ketteler .Copyright \u00a9 2011 Piergiorgio Messa et al .", "label": "", "metadata": {}, "score": "127.9795"}
{"text": "[ Google Scholar ] [ CrossRef ] .\u00a9 2013 by the authors ; licensee MDPI , Basel , Switzerland .Publisher main menu .Follow BioMed Central .", "label": "", "metadata": {}, "score": "130.21686"}
